Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:7,12-dimethyltetraphene
go back to main search page
Accession:CHEBI:254496 term browser browse the term
Definition:A tetraphene having methyl substituents at the 7- and 12-positions. It is a potent carcinogen and is present in tobacco smoke.
Synonyms:related_synonym: 1,4-Dimethyl-2,3-benzphenanthrene;   6,7-Dimethyl-1,2-benzanthracene;   7,12-DMBA;   7,12-Dimethyl-1,2-benzanthracene;   7,12-Dimethyl-1:2-benz(a)anthracene;   7,12-Dimethylbenz(a)anthracene;   7,12-Dimethylbenzanthracene;   7,12-Dimethylbenzanthrancene;   7,12-dimethylbenzo[a]anthracene;   9,10-Dimethyl-1,2-benzanthracene;   9,10-Dimethyl-1,2-benzanthrazen;   9,10-Dimethylbenz(a)anthracene;   DMBA;   Formula=C20H16;   InChI=1S/C20H16/c1-13-16-8-5-6-9-17(16)14(2)20-18(13)12-11-15-7-3-4-10-19(15)20/h3-12H,1-2H3;   InChIKey=ARSRBNBHOADGJU-UHFFFAOYSA-N;   SMILES=Cc1c2ccccc2c(C)c2c1ccc1ccccc21
 alt_id: CHEBI:59032
 xref: Beilstein:1912135;   CAS:57-97-6;   Gmelin:263937;   KEGG:C19488;   LINCS:LSM-37159
 xref_mesh: MESH:D015127
 xref: PMID:11488430;   PMID:12839762;   PMID:16020197;   PMID:18992763;   PMID:7561049



show annotations for term's descendants           Sort by:
7,12-dimethyltetraphene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1b ATP-binding cassette, sub-family B member 1B increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ABCB1B mRNA CTD PMID:32553695 NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
JBrowse link
G Abcc6 ATP binding cassette subfamily C member 6 affects response to substance ISO ABCC6 gene SNP affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene CTD PMID:25622337 NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
JBrowse link
G Abhd3 abhydrolase domain containing 3, phospholipase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ABHD3 mRNA CTD PMID:21527772 NCBI chr18:1,723,203...1,778,488
Ensembl chr18:1,720,718...1,803,428
JBrowse link
G Acad8 acyl-CoA dehydrogenase family, member 8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ACAD8 mRNA CTD PMID:32553695 NCBI chr 8:25,382,271...25,406,404
Ensembl chr 8:25,382,273...25,406,414
JBrowse link
G Acat1 acetyl-CoA acetyltransferase 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ACAT1 protein CTD PMID:38307155 NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
JBrowse link
G Actb actin, beta affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of ACTB mRNA CTD PMID:21785161 NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
JBrowse link
G Actg2 actin gamma 2, smooth muscle increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ACTG2 mRNA CTD PMID:19480007 NCBI chr 4:116,021,832...116,046,475
Ensembl chr 4:116,021,832...116,046,465
JBrowse link
G Actn1 actinin, alpha 1 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ACTN1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ACTN1 protein
CTD PMID:22248470 NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
JBrowse link
G Actn3 actinin alpha 3 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ACTN3 mRNA CTD PMID:19480007 NCBI chr 1:202,159,081...202,175,012
Ensembl chr 1:202,159,082...202,175,012
JBrowse link
G Actn4 actinin alpha 4 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ACTN4 mRNA CTD PMID:12376462 NCBI chr 1:84,182,783...84,251,867
Ensembl chr 1:84,182,788...84,251,847
JBrowse link
G Actr3b actin related protein 3B increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ACTR3B mRNA CTD PMID:19480007 NCBI chr 4:9,261,631...9,355,496
Ensembl chr 4:9,262,233...9,355,441
JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ADAMTS1 mRNA CTD PMID:32553695 NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
JBrowse link
G Adamts9 ADAM metallopeptidase with thrombospondin type 1 motif, 9 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ADAMTS9 mRNA CTD PMID:32553695 NCBI chr 4:125,290,633...125,462,988
Ensembl chr 4:125,291,490...125,462,929
JBrowse link
G Adcy5 adenylate cyclase 5 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ADCY5 mRNA CTD PMID:12376462 NCBI chr11:65,471,612...65,618,877
Ensembl chr11:65,471,612...65,618,974
JBrowse link
G Adgrl4 adhesion G protein-coupled receptor L4 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ADGRL4 mRNA CTD PMID:19480007 NCBI chr 2:240,354,909...240,457,231
Ensembl chr 2:240,354,941...240,457,225
JBrowse link
G Adh7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ADH7 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ADH7 mRNA
CTD PMID:32553695 NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
JBrowse link
G Adm adrenomedullin increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ADM mRNA CTD PMID:19480007 NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
JBrowse link
G Aen apoptosis enhancing nuclease increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of AEN mRNA CTD PMID:32553695 NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
JBrowse link
G Ago2 argonaute RISC catalytic component 2 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 mRNA]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 mRNA]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AGO2 protein]
CTD PMID:24792773 NCBI chr 7:105,018,202...105,105,118
Ensembl chr 7:105,029,120...105,104,974
JBrowse link
G Agxt alanine--glyoxylate aminotransferase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of AGXT protein CTD PMID:38307155 NCBI chr 9:93,675,384...93,685,337
Ensembl chr 9:93,675,384...93,685,336
JBrowse link
G Ahcyl1 adenosylhomocysteinase-like 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of AHCYL1 mRNA CTD PMID:21785161 NCBI chr 2:195,294,149...195,328,586
Ensembl chr 2:195,294,153...195,345,815
JBrowse link
G Ahr aryl hydrocarbon receptor increases activity
decreases expression
multiple interactions
affects localization
affects binding
increases expression
affects response to substance
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of AHR mRNA
9,10-Dimethyl-1,2-benzanthracene promotes the reaction [AHR protein results in increased expression of CCL5 mRNA]; AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA]; AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA]; AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA]; biochanin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [AHR protein binds to CYP1A1 promoter]]; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the localization of AHR protein]
9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of AHR protein; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in decreased expression of CXCL10 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ADH7 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of AHRR mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ALDH3A1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ARL6IP5 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of BTG2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCL2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCNG1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCNO mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CENPB mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CXCL5 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of DDIT4 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of DOK1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of FOSL1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of GCHFR mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of GPRC5A mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of IER3 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of INHBB mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of LPL mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of NFE2L2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of NQO1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PGD mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PHLDA1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PHLDA3 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PTGS2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PTX3 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of SPP1 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of SULF2 mRNA; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of TIPARP mRNA; [AHR mRNA affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which results in decreased expression of CYP1A1; AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARTN protein]; AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL4RA]; AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of TSLP]; galangin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the localization of AHR protein]
9,10-Dimethyl-1,2-benzanthracene binds to AHR protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of AHR mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AHR protein
AHR affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene; AHR mRNA affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of AHR protein; AHR protein promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH13 mRNA]; betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of AHR protein]
CTD PMID:3024361 PMID:9855628 PMID:10953044 PMID:12117779 PMID:12200463 More... NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
JBrowse link
G Ahrr aryl-hydrocarbon receptor repressor multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of AHRR mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of AHRR mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of AHRR mRNA
CTD PMID:27891153 PMID:32553695 NCBI chr 1:28,993,634...29,088,673
Ensembl chr 1:28,993,634...29,088,673
JBrowse link
G Akr1b10 aldo-keto reductase family 1 member B10 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AKR1B10 mRNA CTD PMID:26198647 NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
JBrowse link
G Akr7a2 aldo-keto reductase family 7, member A2 multiple interactions ISO AKR7A2 protein results in increased reduction of and affects the activity of 9,10-Dimethyl-1,2-benzanthracene CTD PMID:21910479 NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases expression
increases phosphorylation
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased expression of AKT1 protein modified form
9,10-Dimethyl-1,2-benzanthracene results in increased expression of AKT1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of AKT1 protein
CTD PMID:21785161 PMID:24576726 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
JBrowse link
G Alas2 5'-aminolevulinate synthase 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ALAS2 mRNA CTD PMID:19480007 NCBI chr  X:19,463,146...19,486,526
Ensembl chr  X:19,463,171...19,486,519
JBrowse link
G Alb albumin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ALB protein CTD PMID:38307155 NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
JBrowse link
G Aldh3a1 aldehyde dehydrogenase 3 family, member A1 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ALDH3A1 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ALDH3A1 mRNA
CTD PMID:32553695 NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
JBrowse link
G Aldoa aldolase, fructose-bisphosphate A increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ALDOA protein CTD PMID:22248470 NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
JBrowse link
G Anapc5 anaphase-promoting complex subunit 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANAPC5 mRNA CTD PMID:21785161 NCBI chr12:33,748,709...33,781,709
Ensembl chr12:33,748,735...33,781,781
JBrowse link
G Angptl4 angiopoietin-like 4 multiple interactions
increases methylation
EXP [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of ANGPTL4 promoter] which results in decreased expression of ANGPTL4 mRNA CTD PMID:21489049 NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
JBrowse link
G Ankh ANKH inorganic pyrophosphate transport regulator increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANK mRNA CTD PMID:19480007 NCBI chr 2:78,153,027...78,280,181
Ensembl chr 2:78,153,026...78,280,187
JBrowse link
G Anxa1 annexin A1 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ANXA1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANXA1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANXA1 protein
CTD PMID:12376462 PMID:22248470 NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
JBrowse link
G Anxa2 annexin A2 multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ANXA2 protein CTD PMID:22248470 NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
JBrowse link
G Anxa8 annexin A8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ANXA8 mRNA CTD PMID:32553695 NCBI chr16:9,397,144...9,412,072
Ensembl chr16:9,397,113...9,412,043
JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 multiple interactions
decreases expression
ISO [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of APAF1 protein
CTD PMID:25478867 NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 multiple interactions
increases expression
ISO Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of APEX1 mRNA] CTD PMID:25697376 NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
JBrowse link
G Apobec1 apolipoprotein B mRNA editing enzyme catalytic subunit 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of APOBEC1 mRNA CTD PMID:32553695 NCBI chr 4:155,800,030...155,828,515
Ensembl chr 4:155,800,887...155,827,390
JBrowse link
G Apoc1 apolipoprotein C1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of APOC1 mRNA CTD PMID:21785161 NCBI chr 1:79,347,057...79,350,340
Ensembl chr 1:79,346,136...79,350,375
JBrowse link
G Apoe apolipoprotein E affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of APOE mRNA CTD PMID:21785161 NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
JBrowse link
G Aqp1 aquaporin 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of AQP1 mRNA CTD PMID:12376462 NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AQP3 mRNA CTD PMID:19480007 NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
JBrowse link
G Aqp5 aquaporin 5 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of AQP5 mRNA CTD PMID:19480007 NCBI chr 7:130,722,675...130,726,207
Ensembl chr 7:130,721,748...130,726,209
JBrowse link
G Ar androgen receptor multiple interactions
increases activity
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene binds to and results in decreased activity of AR protein; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Metribolone results in increased activity of AR protein]
9,10-Dimethyl-1,2-benzanthracene results in increased activity of AR protein
CTD PMID:10771140 PMID:18324785 PMID:33049310 NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925
JBrowse link
G Arhgap11a Rho GTPase activating protein 11A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ARHGAP11A mRNA CTD PMID:32553695 NCBI chr 3:100,590,865...100,607,146
Ensembl chr 3:100,590,865...100,607,559
JBrowse link
G Arhgap6 Rho GTPase activating protein 6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ARHGAP6 mRNA CTD PMID:32553695 NCBI chr  X:24,953,464...25,490,003
Ensembl chr  X:24,953,464...25,488,663
JBrowse link
G Arhgdib Rho GDP dissociation inhibitor beta increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARHGDIB mRNA CTD PMID:21527772 NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
JBrowse link
G Arl16 ARF like GTPase 16 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of ARL16 mRNA CTD PMID:21785161 NCBI chr10:105,737,455...105,739,631
Ensembl chr10:105,737,154...105,739,824
JBrowse link
G Arl6ip5 ARF like GTPase 6 interacting protein 5 multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of ARL6IP5 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ARL6IP5 mRNA
CTD PMID:32553695 NCBI chr 4:129,810,650...129,838,628
Ensembl chr 4:129,810,645...129,838,608
JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator increases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARNT protein
betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARNT protein]
CTD PMID:33759307 NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
JBrowse link
G Arrdc3 arrestin domain containing 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ARRDC3 mRNA CTD PMID:32553695 NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
JBrowse link
G Artn artemin multiple interactions
increases expression
ISO AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARTN protein] CTD PMID:27869817 NCBI chr 5:131,458,596...131,470,193
Ensembl chr 5:131,464,756...131,468,025
JBrowse link
G Asah1 N-acylsphingosine amidohydrolase 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of ASAH1 mRNA CTD PMID:21785161 NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
JBrowse link
G Asip agouti signaling protein multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene affects the reaction [A gene mutant form results in decreased expression of GJA4 protein]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of ATM mRNA]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of BRCA1 protein]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of PRKDC mRNA]; 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [A gene mutant form results in increased expression of PARP1 mRNA]; 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [A gene mutant form results in increased expression of PARP1 protein]; [A gene mutant form co-treated with 9,10-Dimethyl-1,2-benzanthracene] affects the expression of GJA4 protein; A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA]; A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AX protein]; A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 protein]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BRCA1 protein]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 mRNA]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of XRCC6 protein] CTD PMID:25447408 PMID:25448685 NCBI chr 3:143,473,584...143,561,170
Ensembl chr 3:143,555,696...143,561,171
JBrowse link
G Ass1 argininosuccinate synthase 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ASS1 mRNA CTD PMID:32553695 NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
JBrowse link
G Atad2 ATPase family, AAA domain containing 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ATAD2 mRNA CTD PMID:32553695 NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738
JBrowse link
G Atg10 autophagy related 10 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ATG10 mRNA CTD PMID:32553695 NCBI chr 2:22,109,304...22,398,313
Ensembl chr 2:22,108,426...22,398,233
JBrowse link
G Atm ATM serine/threonine kinase multiple interactions
increases expression
decreases expression
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased phosphorylation of ATM protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATM protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ATM mRNA
9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of ATM mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATM mRNA
CTD PMID:23969067 PMID:25448685 NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha increases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATP5F1A protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ATP5F1A protein
CTD PMID:22248470 NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
JBrowse link
G Atp5f1b ATP synthase F1 subunit beta multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ATP5F1B protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATP5F1B protein
CTD PMID:22248470 NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
JBrowse link
G Atp5if1 ATP synthase inhibitory factor subunit 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATP5IF1 mRNA CTD PMID:12376462 NCBI chr 5:144,738,950...144,742,668
Ensembl chr 5:144,738,950...144,742,668
JBrowse link
G Atp6ap2 ATPase H+ transporting accessory protein 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of ATP6AP2 mRNA CTD PMID:21785161 NCBI chr  X:10,183,983...10,210,948
Ensembl chr  X:10,183,068...10,210,918
JBrowse link
G Atrnl1 attractin like 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ATRNL1 mRNA CTD PMID:32553695 NCBI chr 1:256,670,976...257,219,291
Ensembl chr 1:256,670,627...257,213,197
JBrowse link
G Axin1 axin 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of AXIN1 mRNA CTD PMID:36863560 NCBI chr10:15,163,477...15,215,615
Ensembl chr10:15,163,684...15,215,615
JBrowse link
G Axl Axl receptor tyrosine kinase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of AXL mRNA CTD PMID:21527772 NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
JBrowse link
G Basp1 brain abundant, membrane attached signal protein 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BASP1 mRNA CTD PMID:12376462 NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
multiple interactions
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BAX mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BAX mRNA
[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BAX protein; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of BAX protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BAX protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of BAX protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of BAX protein]
alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BAX mRNA]
CTD PMID:20562217 PMID:22760862 PMID:24269759 PMID:25478867 PMID:30101532 More... NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
JBrowse link
G Bbc3 Bcl-2 binding component 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BBC3 mRNA CTD PMID:32553695 NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
JBrowse link
G Bbs9 Bardet-Biedl syndrome 9 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of BBS9 mRNA CTD PMID:32553695 NCBI chr 8:21,013,865...21,437,934
Ensembl chr 8:21,013,944...21,437,930
JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
increases expression
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of BCL2 protein; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]; [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; [Plant Extracts co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of BCL2 protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of BCL2 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of BCL2 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]
[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]; Ghee inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein
CTD PMID:20103723 PMID:20537511 PMID:21088903 PMID:22760862 PMID:25478867 More... NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743
JBrowse link
G Bcl6 BCL6, transcription repressor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BCL6 mRNA CTD PMID:32553695 NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
JBrowse link
G Bdnf brain-derived neurotrophic factor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BDNF mRNA CTD PMID:32553695 NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
JBrowse link
G Becn1 beclin 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BECN1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BECN1 protein CTD PMID:24576726 NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
JBrowse link
G Bmi1 BMI1 proto-oncogene, polycomb ring finger increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein
Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BMI1 protein]
CTD PMID:24792773 NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
JBrowse link
G Brat1 BRCA1-associated ATM activator 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of BRAT1 mRNA CTD PMID:21785161 NCBI chr12:13,928,889...13,951,760
Ensembl chr12:13,928,898...13,941,248
JBrowse link
G Brca1 BRCA1, DNA repair associated affects response to substance
increases expression
multiple interactions
ISO
EXP
BRCA1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of BRCA1 protein
9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of BRCA1 protein]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BRCA1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of BRCA1 mRNA
CTD PMID:21507987 PMID:23969067 PMID:25448685 NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
JBrowse link
G Bscl2 BSCL2 lipid droplet biogenesis associated, seipin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of BSCL2 mRNA CTD PMID:22003191 NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421
JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of BTG2 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of BTG2 mRNA
CTD PMID:32553695 NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
JBrowse link
G C1qb complement C1q B chain affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of C1QB mRNA CTD PMID:21785161 NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
JBrowse link
G C1qc complement C1q C chain affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of C1QC mRNA CTD PMID:21785161 NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017
JBrowse link
G C1s complement C1s affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of C1S mRNA CTD PMID:21785161 NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
JBrowse link
G C3 complement C3 increases expression
decreases expression
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of C3 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of C3 protein
CTD PMID:19480007 PMID:38307155 NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
JBrowse link
G Calr calreticulin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CALR mRNA CTD PMID:21785161 NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
JBrowse link
G Capza2 capping actin protein of muscle Z-line subunit alpha 2 multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of CAPZA2 protein CTD PMID:22248470 NCBI chr 4:45,978,142...46,014,032
Ensembl chr 4:45,977,807...46,013,864
JBrowse link
G Car2 carbonic anhydrase 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CAR2 mRNA CTD PMID:19480007 NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
JBrowse link
G Car3 carbonic anhydrase 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CAR3 protein CTD PMID:20045496 NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280
JBrowse link
G Cask calcium/calmodulin dependent serine protein kinase increases expression
decreases expression
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CASK mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CASK mRNA
CTD PMID:12376462 PMID:32553695 NCBI chr  X:8,899,500...9,243,014
Ensembl chr  X:8,899,833...9,238,694
JBrowse link
G Casp2 caspase 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CASP2 protein CTD PMID:21785161 NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
JBrowse link
G Casp3 caspase 3 multiple interactions
increases cleavage
decreases expression
decreases activity
increases expression
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased cleavage of and results in increased activity of CASP3 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CASP3 protein; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein]; amarogentin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased cleavage of and results in increased activity of CASP3 protein]; aspartyl-glutamyl-valyl-aspartal inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein]; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CASP3 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; CYP1B1 protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP3 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]; pifithrin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein]; Plant Extracts inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased cleavage of and results in increased activity of CASP3 protein]; pyrene inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein]
Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP3 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CASP3 protein
CTD PMID:16517061 PMID:21785161 PMID:23969067 PMID:25478867 PMID:30101532 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
JBrowse link
G Casp9 caspase 9 decreases activity
decreases expression
multiple interactions
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein
Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CASP9 protein; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CASP9 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CASP9 protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CASP9 protein]
CTD PMID:25478867 PMID:30101532 PMID:32662567 PMID:33347706 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
JBrowse link
G Cat catalase multiple interactions
increases activity
decreases expression
decreases activity
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with argemone oil]] results in decreased activity of CAT protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with sanguinarine]] results in decreased activity of CAT protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of CAT protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with argemone oil] results in decreased activity of CAT protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with sanguinarine] results in decreased activity of CAT protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of CAT protein]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CAT protein]; geraniol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CAT protein]
9,10-Dimethyl-1,2-benzanthracene results in increased activity of CAT protein
9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein
[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CAT protein]; allyl isothiocyanate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]; betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]; brucine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]; Vitamin K inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]; zingerone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of CAT protein]
CTD PMID:20691676 PMID:23033690 PMID:24995432 PMID:25744308 PMID:30027798 More... NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
JBrowse link
G Cbln2 cerebellin 2 precursor decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CBLN2 mRNA CTD PMID:19480007 NCBI chr18:79,940,412...79,948,766
Ensembl chr18:79,942,590...79,947,855
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCL2 mRNA
9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]
CTD PMID:32553695 PMID:36416909 NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions
increases expression
EXP citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCL3 mRNA] CTD PMID:31926054 NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions
increases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene promotes the reaction [AHR protein results in increased expression of CCL5 mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCL5 mRNA
CTD PMID:12200463 PMID:19480007 NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
JBrowse link
G Ccl9 C-C motif chemokine ligand 9 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CCL6 mRNA CTD PMID:19480007 NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
JBrowse link
G Ccn2 cellular communication network factor 2 increases expression EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCN2 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CCN2 mRNA
CTD PMID:19480007 PMID:32553695 NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
JBrowse link
G Ccn3 cellular communication network factor 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCN3 mRNA CTD PMID:19480007 NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
JBrowse link
G Ccnb1 cyclin B1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCNB1 protein CTD PMID:20025956 NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
JBrowse link
G Ccnd1 cyclin D1 increases expression
increases expression
multiple interactions
ISO
IEP
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCND1 mRNA
DMBA increases expression of Ccnd1 mRNA and protein in rat mammary gland
[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CCND1 mRNA; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CCND1 mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCND1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCND1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CCND1 protein
CTD
RGD
PMID:12097258 PMID:12376462 PMID:21785161 PMID:29663660 PMID:32662567 More... RGD:2292404 NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
JBrowse link
G Ccng1 cyclin G1 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CCNG1 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCNG1 mRNA
CTD PMID:32553695 NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
JBrowse link
G Ccno cyclin O increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CCNO mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CCNO mRNA
CTD PMID:32553695 NCBI chr 2:44,630,873...44,633,912
Ensembl chr 2:44,626,369...44,633,914
JBrowse link
G Cd109 CD109 molecule increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CD109 mRNA CTD PMID:32553695 NCBI chr 8:79,454,480...79,569,195
Ensembl chr 8:79,454,480...79,569,194
JBrowse link
G Cd14 CD14 molecule increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CD14 mRNA CTD PMID:32553695 NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
JBrowse link
G Cd3d CD3 delta subunit of T-cell receptor complex increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD3D mRNA CTD PMID:19480007 NCBI chr 8:45,287,803...45,293,342
Ensembl chr 8:45,288,749...45,301,809
JBrowse link
G Cd3g CD3 gamma subunit of T-cell receptor complex increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD3G mRNA CTD PMID:19480007 NCBI chr 8:45,280,797...45,287,271
Ensembl chr 8:45,281,204...45,287,147
JBrowse link
G Cd44 CD44 molecule increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CD44 mRNA CTD PMID:32553695 NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
JBrowse link
G Cd5 Cd5 molecule increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD5 mRNA CTD PMID:19480007 NCBI chr 1:207,365,337...207,386,313
Ensembl chr 1:207,365,337...207,386,313
JBrowse link
G Cd52 CD52 molecule decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CD52 mRNA CTD PMID:19480007 NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348
JBrowse link
G Cd59b CD59b molecule multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein CTD PMID:19965957 PMID:20202993 NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
JBrowse link
G Cd6 Cd6 molecule increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD6 mRNA CTD PMID:19480007 NCBI chr 1:207,442,873...207,481,703
Ensembl chr 1:207,442,877...207,481,634
JBrowse link
G Cd74 CD74 molecule affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CD74 mRNA CTD PMID:21785161 NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
JBrowse link
G Cd80 Cd80 molecule increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CD80 mRNA CTD PMID:32553695 NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030
JBrowse link
G Cd81 Cd81 molecule affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CD81 protein CTD PMID:38307155 NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
JBrowse link
G Cd93 CD93 molecule increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CD93 mRNA CTD PMID:19480007 NCBI chr 3:135,891,859...135,898,378
Ensembl chr 3:135,891,859...135,898,378
JBrowse link
G Cdh1 cadherin 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH1 protein CTD PMID:29663660 NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
JBrowse link
G Cdh13 cadherin 13 multiple interactions
decreases expression
EXP AHR protein promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH13 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDH13 mRNA] CTD PMID:12559965 PMID:19480007 NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
JBrowse link
G Cdk4 cyclin-dependent kinase 4 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDK4 mRNA CTD PMID:12376462 NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
JBrowse link
G Cdkal1 CDK5 regulatory subunit associated protein 1-like 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CDKAL1 mRNA CTD PMID:32553695 NCBI chr17:34,718,701...35,271,276
Ensembl chr17:34,718,687...35,407,524
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein
[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; [Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]; [epigallocatechin gallate co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]; [Plant Extracts co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]; [Resveratrol co-treated with Ellagic Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]; [theaflavin co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN1A protein]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CDKN1A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN1A protein
CTD PMID:20043298 PMID:20103723 PMID:21527772 PMID:21785161 PMID:23717041 More... NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A increases response to substance
multiple interactions
increases methylation
decreases expression
ISO CDKN2A gene polymorphism results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene
Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CDKN2A promoter]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CDKN2A promoter]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CDKN2A promoter]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CDKN2A protein
CTD PMID:11544531 PMID:24792773 NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
JBrowse link
G Cdkn2b cyclin-dependent kinase inhibitor 2B increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CDKN2B mRNA CTD PMID:19480007 NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 increases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CEACAM5 protein
zingerone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CEACAM5 protein]
CTD PMID:31476248 NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
JBrowse link
G Celf5 CUGBP, Elav-like family member 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CELF5 mRNA CTD PMID:32553695 NCBI chr 7:8,225,787...8,250,322
Ensembl chr 7:8,225,825...8,250,322
JBrowse link
G Cenpb centromere protein B multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CENPB mRNA CTD PMID:32553695 NCBI chr 3:118,396,987...118,399,780
Ensembl chr 3:118,388,546...118,400,470
JBrowse link
G Cep112 centrosomal protein 112 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CEP112 mRNA CTD PMID:32553695 NCBI chr10:93,366,059...93,833,133
Ensembl chr10:93,366,136...93,833,131
JBrowse link
G Cercam cerebral endothelial cell adhesion molecule decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CERCAM mRNA CTD PMID:19480007 NCBI chr 3:13,118,150...13,155,960
Ensembl chr 3:13,142,107...13,155,956
JBrowse link
G Cfd complement factor D decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CFD mRNA CTD PMID:19480007 NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053
JBrowse link
G Cgref1 cell growth regulator with EF hand domain 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CGREF1 mRNA CTD PMID:32553695 NCBI chr 6:25,431,846...25,443,853
Ensembl chr 6:25,431,799...25,443,852
JBrowse link
G Chchd6 coiled-coil-helix-coiled-coil-helix domain containing 6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CHCHD6 mRNA CTD PMID:32553695 NCBI chr 4:121,803,501...122,024,209
Ensembl chr 4:121,792,717...122,024,216
JBrowse link
G Chek1 checkpoint kinase 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CHEK1 protein CTD PMID:20025956 NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
JBrowse link
G Chi3l1 chitinase 3 like 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CHI3L1 mRNA CTD PMID:21785161 NCBI chr13:45,641,802...45,649,787
Ensembl chr13:45,641,802...45,649,787
JBrowse link
G Cidec cell death-inducing DFFA-like effector c decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CIDEC mRNA CTD PMID:19480007 NCBI chr 4:146,569,288...146,582,173
Ensembl chr 4:146,569,289...146,582,173
JBrowse link
G Cisd1 CDGSH iron sulfur domain 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CISD1 protein CTD PMID:38307155 NCBI chr20:17,255,302...17,268,688
Ensembl chr20:17,255,151...17,284,924
JBrowse link
G Ckap2 cytoskeleton associated protein 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CKAP2 mRNA CTD PMID:32553695 NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913
JBrowse link
G Clca1 chloride channel accessory 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CLCA1 mRNA CTD PMID:19480007 NCBI chr 2:233,938,677...233,964,369
Ensembl chr 2:233,938,677...233,964,369
JBrowse link
G Cldn3 claudin 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CLDN3 mRNA CTD PMID:12097258 NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
JBrowse link
G Clec10a C-type lectin domain containing 10A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CLEC10A mRNA CTD PMID:32553695 NCBI chr10:54,876,244...54,880,439
Ensembl chr10:54,876,260...54,880,435
JBrowse link
G Clstn3 calsyntenin 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CLSTN3 mRNA CTD PMID:32553695 NCBI chr 4:157,331,494...157,364,769
Ensembl chr 4:157,331,494...157,364,769
JBrowse link
G Cnn3 calponin 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CNN3 mRNA CTD PMID:12376462 NCBI chr 2:209,518,948...209,550,107
Ensembl chr 2:209,518,948...209,550,104
JBrowse link
G Col1a2 collagen type I alpha 2 chain decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COL1A2 mRNA CTD PMID:19480007 NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
JBrowse link
G Col4a6 collagen type IV alpha 6 chain decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of COL4A6 mRNA CTD PMID:32553695 NCBI chr  X:104,766,463...105,117,499
Ensembl chr  X:104,766,957...105,117,500
JBrowse link
G Col5a1 collagen type V alpha 1 chain decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COL5A1 mRNA CTD PMID:12376462 NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
JBrowse link
G Col5a3 collagen type V alpha 3 chain decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COL5A3 mRNA CTD PMID:19480007 NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853
JBrowse link
G Colec10 collectin subfamily member 10 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of COLEC10 mRNA CTD PMID:32553695 NCBI chr 7:85,744,895...85,806,368
Ensembl chr 7:85,744,895...85,805,675
JBrowse link
G Comt catechol-O-methyltransferase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COMT mRNA CTD PMID:38307155 NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
JBrowse link
G Coro1a coronin 1A increases methylation
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CORO1A promoter
[9,10-Dimethyl-1,2-benzanthracene results in increased methylation of CORO1A promoter] which results in decreased expression of CORO1A mRNA
CTD PMID:21489049 NCBI chr 1:181,295,561...181,300,566
Ensembl chr 1:181,295,562...181,300,534
JBrowse link
G Cox6c cytochrome c oxidase subunit 6C increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of COX6C protein CTD PMID:38307155 NCBI chr 7:67,129,265...67,142,001
Ensembl chr 7:67,111,024...67,141,963
JBrowse link
G Cpa6 carboxypeptidase A6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CPA6 mRNA CTD PMID:32553695 NCBI chr 5:8,526,708...8,888,492
Ensembl chr 5:8,526,741...8,888,485
JBrowse link
G Cpb1 carboxypeptidase B1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CPB1 mRNA CTD PMID:32553695 NCBI chr 2:102,755,241...102,785,628
Ensembl chr 2:102,755,241...102,785,628
JBrowse link
G Cpox coproporphyrinogen oxidase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CPOX mRNA CTD PMID:32553695 NCBI chr11:41,936,585...41,946,568
Ensembl chr11:41,936,591...41,946,746
JBrowse link
G Crabp2 cellular retinoic acid binding protein 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CRABP2 mRNA CTD PMID:21527772 NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CREB3L3 mRNA CTD PMID:27891153 NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
JBrowse link
G Crp C-reactive protein multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein]] CTD PMID:37352108 NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
JBrowse link
G Csde1 cold shock domain containing E1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CSDE1 mRNA CTD PMID:21785161 NCBI chr 2:190,546,015...190,582,787
Ensembl chr 2:190,554,980...190,582,784
JBrowse link
G Csf1r colony stimulating factor 1 receptor multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Fluoxetine] affects the expression of CSF1R protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride co-treated with Fluoxetine] affects the expression of CSF1R protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride] affects the expression of CSF1R protein CTD PMID:31332895 NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
JBrowse link
G Csf2 colony stimulating factor 2 increases expression
multiple interactions
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CSF2 mRNA
Vitamin K inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CSF2 mRNA]
CTD PMID:14678569 PMID:33063951 NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
JBrowse link
G Csf3 colony stimulating factor 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CSF3 mRNA CTD PMID:14678569 NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
JBrowse link
G Csn1s1 casein alpha s1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CSN1S1 mRNA CTD PMID:19480007 NCBI chr14:20,343,620...20,359,614
Ensembl chr14:20,343,619...20,359,614
JBrowse link
G Csn2 casein beta decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CSN2 protein CTD PMID:22248470 NCBI chr14:20,322,581...20,329,818
Ensembl chr14:20,322,581...20,329,817
JBrowse link
G Cth cystathionine gamma-lyase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CTH mRNA CTD PMID:32553695 NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
JBrowse link
G Ctnnb1 catenin beta 1 increases expression
decreases expression
multiple interactions
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTNNB1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CTNNB1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of and affects the localization of CTNNB1 protein; mithramycin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of and affects the localization of CTNNB1 protein]; SP1 protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTNNB1 protein]
CTD PMID:29663660 PMID:36863560 NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
JBrowse link
G Ctsd cathepsin D increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTSD mRNA CTD PMID:12097258 NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
JBrowse link
G Ctsw cathepsin W increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CTSW mRNA CTD PMID:19480007 NCBI chr 1:202,772,395...202,777,021
Ensembl chr 1:202,772,572...202,775,964
JBrowse link
G Cubn cubilin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CUBN mRNA CTD PMID:32553695 NCBI chr17:76,385,046...76,593,133
Ensembl chr17:76,385,060...76,593,231
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in decreased expression of CXCL10 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CXCL10 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CXCL10 mRNA
CTD PMID:27891153 PMID:32553695 NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
JBrowse link
G Cxcl13 C-X-C motif chemokine ligand 13 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CXCL13 mRNA CTD PMID:21785161 NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CXCL1 mRNA CTD PMID:32553695 NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
JBrowse link
G Cxcl6 C-X-C motif chemokine ligand 6 multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CXCL5 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CXCL5 mRNA
CTD PMID:32553695 NCBI chr14:17,310,790...17,312,250
Ensembl chr14:17,310,426...17,313,093
JBrowse link
G Cxcr6 C-X-C motif chemokine receptor 6 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CXCR6 mRNA CTD PMID:32553695 NCBI chr 8:123,434,417...123,439,568
Ensembl chr 8:123,416,325...123,439,526
JBrowse link
G Cyb5a cytochrome b5 type A multiple interactions
increases expression
EXP tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYB5A protein]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYB5A protein] CTD PMID:24995432 PMID:27091720 NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535
Ensembl chr18:78,202,342...78,258,535
JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of CYB5R3 mRNA CTD PMID:21785161 NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases response to substance
increases metabolic processing
increases expression
multiple interactions
affects response to substance
increases activity
ISO
EXP
CYP1A1 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene
CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein
7-ketocholesterol inhibits the reaction [[Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 mRNA]; 7-ketocholesterol inhibits the reaction [[Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein]; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1A1 protein; [Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 mRNA; [Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein; betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein]; Estradiol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [[Benzo(a)pyrene co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of CYP1A1 protein]
CYP1A1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CYP1A1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein
2'-hydroxychalcone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; 5-androstene-16-fluoro-17-one inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; 7-ketocholesterol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein]; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1A1 protein; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene; [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form; [Tetrachlorodibenzodioxin promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol; biochanin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [AHR protein binds to CYP1A1 promoter]]; biochanin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; biochanin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; CYP1A1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene; Dehydroepiandrosterone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; Dehydroepiandrosterone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; Eugenol inhibits the reaction [CYP1A1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein]; Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1A1 protein]; Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A1 protein]; S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]
1-(1-propynyl)pyrene inhibits the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1A1 protein; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CYP1A1 mRNA; [[benzo(c)phenanthrene results in increased expression of CYP1A1 protein] promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog; [AHR mRNA affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which results in decreased expression of CYP1A1; [benzo(c)phenanthrene promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog; [CYP1A1 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CYP1A1 mRNA; [Tetrachlorodibenzodioxin promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]
CTD PMID:7756127 PMID:8674863 PMID:8961944 PMID:9168260 PMID:10051580 More... NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 increases activity
multiple interactions
increases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1A2 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 protein
2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1A2 protein]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]; [CYP1A2 protein co-treated with Trichloroepoxypropane] results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]; S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]
CYP1A2 protein results in increased activity of 9,10-Dimethyl-1,2-benzanthracene
CTD PMID:8961944 PMID:15606143 PMID:16054776 PMID:17183067 PMID:18678235 More... NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases activity
increases metabolic processing
increases expression
multiple interactions
affects response to substance
increases response to substance
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein
CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA
2'-hydroxychalcone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; 2,4,3',5'-tetramethoxystilbene inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form]; 2,4,3',5'-tetramethoxystilbene inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; 2-((2,6-dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl ester inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein]; 3-(3-methoxyphenyl)-N-(3,4,5-trimethoxyphenyl)acrylamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; 5-androstene-16-fluoro-17-one inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [[benzo(c)phenanthrene results in increased expression of CYP1B1 protein] promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] which results in increased chemical synthesis of 9,10-Dimethyl-1,2-benzanthracene analog; [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form; alpha-naphthoflavone inhibits the reaction [[CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] which results in increased expression of TP53 protein modified form]; alpha-naphthoflavone inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; CYP1B1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene; Eugenol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; Eugenol inhibits the reaction [CYP1B1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein]; S-sulindac inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein
Estradiol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; POMC protein promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]
1-ethynylpyrene inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of CYP1B1 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Dietary Fats] results in decreased expression of CYP1B1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of AHRR mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CREB3L3 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CXCL10 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of CYP1A1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of EGR2 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of ERDR1X mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HBB-B1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HOXB6 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HSPA1A mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of IL6 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of NR4A1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of POLR2A mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of RAG1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of SOX19 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of SPP1 mRNA; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of TNF mRNA; [Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; [Resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein]; benz(a)anthracene promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; chelerythrine inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; CYP1B1 protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased cleavage of CASP3 protein]; CYP1B1 protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of TRP53 protein]; Dehydroepiandrosterone inhibits the reaction [benz(a)anthracene promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]; Dehydroepiandrosterone inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; Dehydroepiandrosterone inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]; pifithrin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein]; POR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein]; PRKCB protein inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; PRKCB protein inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]; pyrene inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP1B1 protein]; Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; Tetradecanoylphorbol Acetate inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; Tetradecanoylphorbol Acetate inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of CYP1B1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein
CYP1B1 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene; CYP1B1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene
CYP1B1 protein results in increased activity of 9,10-Dimethyl-1,2-benzanthracene
CTD PMID:7505439 PMID:7588239 PMID:8033136 PMID:8674863 PMID:9168260 More... NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 increases activity
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP2B1 protein
beta-Naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP2B1 protein]
CTD PMID:16054776 NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 increases activity
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP2B2 protein
beta-Naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of CYP2B2 protein]
CTD PMID:16054776 NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions ISO CYP2B6 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene CTD PMID:32159784 NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 multiple interactions
increases expression
ISO CYP2C19 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP2C29 mRNA
CTD PMID:32159784 PMID:38307155 NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 increases response to substance ISO CYP2D6 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene CTD PMID:20507880 NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 affects response to substance
increases expression
ISO
EXP
CYP2E1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP2E1 mRNA
CTD PMID:18622027 PMID:24576726 NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
JBrowse link
G Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1 multiple interactions ISO [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of 9,10-Dimethyl-1,2-benzanthracene CTD PMID:19713358 NCBI chr 1:81,309,948...81,325,303
Ensembl chr 1:81,310,451...81,325,303
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases response to substance ISO CYP3A4 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene CTD PMID:20507880 NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
JBrowse link
G Dars1 aspartyl-tRNA synthetase 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of DARS1 mRNA CTD PMID:21785161 NCBI chr13:39,857,936...39,913,055
Ensembl chr13:39,857,936...39,913,116
JBrowse link
G Dazl deleted in azoospermia-like decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DAZL mRNA
AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DAZL mRNA]
CTD PMID:20562217 NCBI chr 9:10,695,593...10,712,330
Ensembl chr 9:10,695,592...10,712,323
JBrowse link
G Dbi diazepam binding inhibitor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DBI mRNA CTD PMID:12376462 NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
JBrowse link
G Dchs1 dachsous cadherin-related 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DCHS1 mRNA CTD PMID:19480007 NCBI chr 1:160,104,931...160,138,958
Ensembl chr 1:160,104,931...160,124,808
JBrowse link
G Dcn decorin multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of DCN protein CTD PMID:22248470 NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
JBrowse link
G Dcxr dicarbonyl and L-xylulose reductase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DCXR mRNA CTD PMID:32553695 NCBI chr10:106,006,404...106,008,293 JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DDIT3 mRNA CTD PMID:32553695 NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of DDIT4 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DDIT4 mRNA
CTD PMID:32553695 NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
JBrowse link
G Ddit4l DNA-damage-inducible transcript 4-like increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DDIT4L mRNA CTD PMID:32553695 NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
JBrowse link
G Ddrgk1 DDRGK domain containing 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DDRGK1 protein CTD PMID:38307155 NCBI chr 3:117,861,916...117,882,680
Ensembl chr 3:117,861,653...117,882,680
JBrowse link
G Ddx21 DExD-box helicase 21 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DDX21 protein CTD PMID:38307155 NCBI chr20:30,534,319...30,554,513
Ensembl chr20:30,534,319...30,554,543
JBrowse link
G Ddx39b DExD-box helicase 39B multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of DDX39B protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of DDX39B protein
CTD PMID:22248470 NCBI chr20:3,547,702...3,585,064
Ensembl chr20:3,572,056...3,584,996
JBrowse link
G Ddx4 DEAD-box helicase 4 decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DDX4 mRNA
AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DDX4 mRNA]
CTD PMID:20562217 NCBI chr 2:44,227,946...44,282,867
Ensembl chr 2:44,227,946...44,282,723
JBrowse link
G Ddx5 DEAD-box helicase 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DDX5 mRNA CTD PMID:21785161 NCBI chr10:91,723,508...91,732,210
Ensembl chr10:91,723,508...91,732,283
JBrowse link
G Des desmin decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DES mRNA CTD PMID:12376462 NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
JBrowse link
G Dhcr7 7-dehydrocholesterol reductase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DHCR7 mRNA CTD PMID:32553695 NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
JBrowse link
G Dicer1 dicer 1 ribonuclease III increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 mRNA]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 mRNA]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DICER1 protein]
CTD PMID:24792773 NCBI chr 6:123,627,529...123,692,278
Ensembl chr 6:123,631,250...123,693,965
JBrowse link
G Dido1 death inducer-obliterator 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DIDO1 mRNA CTD PMID:32553695 NCBI chr 3:167,772,535...167,825,894
Ensembl chr 3:167,772,770...167,817,218
JBrowse link
G Dio3 iodothyronine deiodinase 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DIO3 mRNA CTD PMID:32553695 NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
JBrowse link
G Dnajb6 DnaJ heat shock protein family (Hsp40) member B6 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNAJB6 mRNA CTD PMID:21785161 NCBI chr 4:5,452,683...5,556,679
Ensembl chr 4:5,452,683...5,556,659
JBrowse link
G Dnajc9 DnaJ heat shock protein family (Hsp40) member C9 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DNAJC9 mRNA CTD PMID:32553695 NCBI chr15:3,923,842...3,928,118
Ensembl chr15:3,923,268...3,928,118
JBrowse link
G Dnmt1 DNA methyltransferase 1 increases expression
multiple interactions
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 protein
CTD PMID:12097258 PMID:24792773 NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
JBrowse link
G Dock9 dedicator of cytokinesis 9 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of DOCK9 mRNA CTD PMID:32553695 NCBI chr15:98,611,518...98,883,306
Ensembl chr15:98,618,084...98,883,153
JBrowse link
G Dok1 docking protein 1 multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of DOK1 mRNA CTD PMID:32553695 NCBI chr 4:115,537,453...115,540,464
Ensembl chr 4:115,537,462...115,540,465
JBrowse link
G Dpt dermatopontin decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of DPT mRNA CTD PMID:19480007 NCBI chr13:77,123,224...77,151,646
Ensembl chr13:77,123,115...77,151,639
JBrowse link
G Dpysl4 dihydropyrimidinase-like 4 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DPYSL4 mRNA CTD PMID:21527772 NCBI chr 1:193,883,039...193,898,916
Ensembl chr 1:193,883,106...193,898,914
JBrowse link
G Dynll2 dynein light chain LC8-type 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of DYNLL2 mRNA CTD PMID:21785161 NCBI chr10:72,767,035...72,785,824
Ensembl chr10:72,767,035...72,785,805
JBrowse link
G Dyrk3 dual specificity tyrosine phosphorylation regulated kinase 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DYRK3 mRNA CTD PMID:32553695 NCBI chr13:42,594,120...42,604,898
Ensembl chr13:42,594,121...42,604,778
JBrowse link
G E2f8 E2F transcription factor 8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of E2F8 mRNA CTD PMID:32553695 NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
JBrowse link
G Ecrg4 ECRG4 augurin precursor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ECRG4 mRNA CTD PMID:19480007 NCBI chr 9:45,992,954...46,012,605
Ensembl chr 9:45,992,954...46,012,595
JBrowse link
G Eda2r ectodysplasin A2 receptor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of EDA2R mRNA CTD PMID:32553695 NCBI chr  X:62,224,763...62,269,333
Ensembl chr  X:62,228,229...62,269,268
JBrowse link
G Ednrb endothelin receptor type B decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EDNRB mRNA CTD PMID:19480007 NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 increases expression EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of EEF1A1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of EEF1A1 protein
CTD PMID:12376462 PMID:20045496 NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
JBrowse link
G Eef2 eukaryotic translation elongation factor 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of EEF2 mRNA CTD PMID:21785161 NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
JBrowse link
G Efemp1 EGF containing fibulin extracellular matrix protein 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EFEMP1 mRNA CTD PMID:12376462 NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
JBrowse link
G Efnb2 ephrin B2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of EFNB2 mRNA CTD PMID:32553695 NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
JBrowse link
G Egfr epidermal growth factor receptor decreases expression ISO
EXP
9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of EGFR mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EGFR mRNA
CTD PMID:32553695 PMID:36863560 NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
JBrowse link
G Egr1 early growth response 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EGR1 mRNA CTD PMID:19480007 NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
JBrowse link
G Egr2 early growth response 2 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of EGR2 mRNA CTD PMID:27891153 NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
JBrowse link
G Ei24 EI24, autophagy associated transmembrane protein increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of EI24 mRNA CTD PMID:32553695 NCBI chr 8:36,494,289...36,510,653
Ensembl chr 8:36,494,289...36,510,571
JBrowse link
G Eif2s2 eukaryotic translation initiation factor 2 subunit beta decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EIF2S2 protein CTD PMID:38307155 NCBI chr 3:143,374,652...143,395,460
Ensembl chr 3:143,373,686...143,395,432
JBrowse link
G Eif4b eukaryotic translation initiation factor 4B affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of EIF4B mRNA CTD PMID:21785161 NCBI chr 7:133,206,637...133,228,436 JBrowse link
G Eif4g2 eukaryotic translation initiation factor 4, gamma 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of EIF4G2 mRNA CTD PMID:21785161 NCBI chr 1:165,181,433...165,193,583
Ensembl chr 1:165,181,434...165,193,588
JBrowse link
G Emp1 epithelial membrane protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EMP1 mRNA CTD PMID:21527772 NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
JBrowse link
G Emp3 epithelial membrane protein 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EMP3 mRNA CTD PMID:21527772 NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
JBrowse link
G Eno1 enolase 1 multiple interactions
increases expression
decreases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ENO1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of ENO1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ENO1 protein
CTD PMID:12376462 PMID:22248470 NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
Ensembl chr 3:160,719,951...160,731,336
JBrowse link
G Enox1 ecto-NOX disulfide-thiol exchanger 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ENOX1 mRNA CTD PMID:32553695 NCBI chr15:52,517,833...53,079,752
Ensembl chr15:52,515,178...53,079,749
JBrowse link
G Enox2 ecto-NOX disulfide-thiol exchanger 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ENOX2 mRNA CTD PMID:32553695 NCBI chr  X:128,270,941...128,593,074
Ensembl chr  X:128,271,074...128,593,039
JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ENPP2 mRNA CTD PMID:32553695 NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
JBrowse link
G Epb41l4b erythrocyte membrane protein band 4.1 like 4B decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of EPB41L4B mRNA CTD PMID:32553695 NCBI chr 5:71,691,706...71,852,583
Ensembl chr 5:71,694,331...71,851,990
JBrowse link
G Ephx1 epoxide hydrolase 1 multiple interactions
increases expression
decreases expression
affects response to substance
increases response to substance
ISO
EXP
EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of EPHX1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EPHX1 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EPHX1 mRNA
EPHX1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
EPHX1 protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene; EPHX1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene
[cyclohexene oxide results in decreased activity of EPHX1 protein] which results in decreased susceptibility to 9,10-Dimethyl-1,2-benzanthracene; EPHX1 protein promotes the reaction [CYP1A1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; EPHX1 protein promotes the reaction [CYP1A2 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; EPHX1 protein results in increased metabolism of and results in increased activity of 9,10-Dimethyl-1,2-benzanthracene
CTD PMID:8961944 PMID:11323178 PMID:12376462 PMID:15331171 PMID:17204581 More... NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
JBrowse link
G Epo erythropoietin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EPO mRNA CTD PMID:19502547 NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ERCC1 mRNA
[epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ERCC1 mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ERCC1 mRNA]; epigallocatechin gallate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ERCC1 mRNA]
CTD PMID:23717041 NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
JBrowse link
G Erp29 endoplasmic reticulum protein 29 multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of ERP29 protein CTD PMID:22248470 NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
JBrowse link
G Esco2 establishment of sister chromatid cohesion N-acetyltransferase 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ESCO2 mRNA CTD PMID:32553695 NCBI chr15:40,034,566...40,052,295
Ensembl chr15:40,034,568...40,055,306
Ensembl chr15:40,034,568...40,055,306
JBrowse link
G Esr1 estrogen receptor 1 decreases expression
multiple interactions
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ESR1 protein
9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of ESR1 protein
[Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of ESR1 protein; [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of ESR1 protein
CTD PMID:16891317 PMID:33049310 NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
JBrowse link
G Esr2 estrogen receptor 2 multiple interactions
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of ESR2 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ESR2 mRNA
CTD PMID:33049310 PMID:36863560 NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
JBrowse link
G Evi2a ecotropic viral integration site 2A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of EVI2A mRNA CTD PMID:32553695 NCBI chr10:64,485,760...64,489,660
Ensembl chr10:64,485,200...64,489,843
JBrowse link
G Exoc3l4 exocyst complex component 3-like 4 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of EXOC3L4 mRNA CTD PMID:19480007 NCBI chr 6:130,452,680...130,466,684
Ensembl chr 6:130,452,661...130,466,683
JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit multiple interactions ISO [sodium arsenite results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate]] which results in increased expression of EZH2 protein CTD PMID:35364107 NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
JBrowse link
G Ezr ezrin multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of EZR protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of EZR mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of EZR protein
CTD PMID:12376462 PMID:22248470 NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
JBrowse link
G Fas Fas cell surface death receptor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of FAS mRNA CTD PMID:32553695 NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
JBrowse link
G Fasn fatty acid synthase multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of FASN protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of FASN protein
CTD PMID:22248470 NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
JBrowse link
G Fbn2 fibrillin 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FBN2 mRNA CTD PMID:19480007 NCBI chr18:51,499,670...51,703,976
Ensembl chr18:51,499,737...51,703,976
JBrowse link
G Fcgbp Fc gamma binding protein increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FCGBP protein CTD PMID:38307155 NCBI chr 1:83,374,979...83,413,082
Ensembl chr 1:83,372,127...83,413,083
JBrowse link
G Fdps farnesyl diphosphate synthase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of FDPS mRNA CTD PMID:32553695 NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
JBrowse link
G Fga fibrinogen alpha chain decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FGA protein CTD PMID:38307155 NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
JBrowse link
G Fhit fragile histidine triad diadenosine triphosphatase decreases expression
increases methylation
EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FHIT mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FHIT protein
9,10-Dimethyl-1,2-benzanthracene results in increased methylation of FHIT intron; 9,10-Dimethyl-1,2-benzanthracene results in increased methylation of FHIT promoter
CTD PMID:15937960 NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
JBrowse link
G Fhl2 four and a half LIM domains 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FHL2 mRNA CTD PMID:19480007 NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192
JBrowse link
G Fhod3 formin homology 2 domain containing 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of FHOD3 mRNA CTD PMID:32553695 NCBI chr18:15,993,079...16,425,796
Ensembl chr18:15,993,324...16,425,796
JBrowse link
G Fip1l1 factor interacting with PAPOLA and CPSF1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FIP1L1 protein CTD PMID:38307155 NCBI chr14:33,615,210...33,675,742
Ensembl chr14:33,617,720...33,675,708
JBrowse link
G Flnc filamin C increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FLNC mRNA CTD PMID:21527772 NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,034,189...58,061,844
JBrowse link
G Fn1 fibronectin 1 multiple interactions
decreases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of FN1 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FN1 mRNA
CTD PMID:12376462 PMID:22248470 NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA; [Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; [Resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOS mRNA]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA]]
CTD PMID:20103723 PMID:37352108 NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of FOSL1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOSL1 protein
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of FOSL1 mRNA
CTD PMID:20025956 PMID:32553695 NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
JBrowse link
G Foxa2 forkhead box A2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOXA2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOXA2 protein CTD PMID:36863560 NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
JBrowse link
G Foxn3 forkhead box N3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOXN3 mRNA CTD PMID:21785161 NCBI chr 6:118,462,018...118,842,442
Ensembl chr 6:118,466,025...118,842,401
JBrowse link
G Foxo3 forkhead box O3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FOXO3 protein CTD PMID:21785161 NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
JBrowse link
G Frat2 FRAT regulator of WNT signaling pathway 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of FRAT2 mRNA CTD PMID:32553695 NCBI chr 1:240,654,120...240,656,449
Ensembl chr 1:240,654,137...240,656,517
JBrowse link
G Fth1 ferritin heavy chain 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FTH1 protein CTD PMID:38307155 NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
JBrowse link
G Furin furin (paired basic amino acid cleaving enzyme) increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of FURIN mRNA CTD PMID:12376462 NCBI chr 1:134,348,142...134,361,182
Ensembl chr 1:134,348,144...134,364,314
JBrowse link
G Fus Fus RNA binding protein affects expression
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene affects the expression of FUS mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FUS mRNA
CTD PMID:19480007 PMID:21785161 NCBI chr 1:182,576,479...182,590,417
Ensembl chr 1:182,576,545...182,590,414
JBrowse link
G G3bp1 G3BP stress granule assembly factor 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of G3BP1 protein CTD PMID:38307155 NCBI chr10:39,586,864...39,620,268
Ensembl chr10:39,586,864...39,620,268
JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha multiple interactions
increases expression
ISO [epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of GADD45A mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of GADD45A mRNA]; epigallocatechin gallate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of GADD45A mRNA]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GADD45A mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GADD45A mRNA
CTD PMID:23717041 PMID:32553695 NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
JBrowse link
G Galnt13 polypeptide N-acetylgalactosaminyltransferase 13 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GALNT13 mRNA CTD PMID:32553695 NCBI chr 3:38,903,695...39,560,683
Ensembl chr 3:38,974,490...39,558,803
JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase decreases expression
increases expression
multiple interactions
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GAPDH mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of GAPDH protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of GAPDH protein
CTD PMID:19502547 PMID:22248470 NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
JBrowse link
G Gas5 growth arrest specific 5 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GAS5 mRNA CTD PMID:19480007 NCBI chr13:73,303,611...73,306,932 JBrowse link
G Gbe1 1,4-alpha-glucan branching enzyme 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GBE1 mRNA CTD PMID:32553695 NCBI chr11:8,734,806...9,000,226
Ensembl chr11:8,734,820...9,000,210
JBrowse link
G Gbp5 guanylate binding protein 5 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GBP5 mRNA CTD PMID:19480007 NCBI chr 2:231,237,748...231,257,071
Ensembl chr 2:231,237,748...231,257,061
JBrowse link
G Gcat glycine C-acetyltransferase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GCAT protein CTD PMID:38307155 NCBI chr 7:110,595,126...110,601,474
Ensembl chr 7:110,595,091...110,601,473
JBrowse link
G Gchfr GTP cyclohydrolase I feedback regulator increases expression
decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GCHFR mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GCHFR protein
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of GCHFR mRNA
CTD PMID:32553695 PMID:38307155 NCBI chr 3:106,158,046...106,162,080
Ensembl chr 3:106,159,394...106,162,080
JBrowse link
G Gda guanine deaminase decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GDA mRNA CTD PMID:12376462 NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
JBrowse link
G Gdf15 growth differentiation factor 15 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GDF15 mRNA CTD PMID:32553695 NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
JBrowse link
G Get3 guided entry of tail-anchored proteins factor 3, ATPase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GET3 mRNA CTD PMID:38307155 NCBI chr19:23,130,109...23,138,196
Ensembl chr19:23,130,109...23,138,193
JBrowse link
G Ggt1 gamma-glutamyltransferase 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GGT1 mRNA CTD PMID:12376462 NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
JBrowse link
G Ggta1 glycoprotein alpha-galactosyltransferase 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GGTA1 mRNA CTD PMID:32553695 NCBI chr 3:18,732,985...18,824,916
Ensembl chr 3:18,732,991...18,809,908
JBrowse link
G Gh1 growth hormone 1 decreases response to substance EXP GH1 gene mutant form results in decreased susceptibility to 9,10-Dimethyl-1,2-benzanthracene CTD PMID:12082019 NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
JBrowse link
G Gimap5 GTPase, IMAP family member 5 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GIMAP5 mRNA CTD PMID:19480007 NCBI chr 4:77,693,417...77,701,025
Ensembl chr 4:77,687,564...77,703,086
JBrowse link
G Gja1 gap junction protein, alpha 1 multiple interactions
decreases expression
increases expression
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] affects the expression of GJA1 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased expression of GJA1 mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of GJA1 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GJA1 mRNA; A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA]
9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Cycloheximide results in decreased expression of GJA1 protein]; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of and results in decreased stability of GJA1 mRNA; Chir 99021 promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA]; Chir 99021 promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 protein]; Dactinomycin promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA]; pyrazolanthrone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of GJA1 protein
CTD PMID:7586191 PMID:24269759 PMID:25447408 PMID:36863560 NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
JBrowse link
G Gja4 gap junction protein, alpha 4 decreases expression
multiple interactions
increases expression
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA4 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GJA4 protein
9,10-Dimethyl-1,2-benzanthracene affects the reaction [A gene mutant form results in decreased expression of GJA4 protein]; [A gene mutant form co-treated with 9,10-Dimethyl-1,2-benzanthracene] affects the expression of GJA4 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of GJA4 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GJA4 protein
CTD PMID:24269759 PMID:25447408 NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925
JBrowse link
G Gjb2 gap junction protein, beta 2 multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] affects the expression of GJB2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of GJB2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of GJB2 mRNA CTD PMID:7586191 NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
JBrowse link
G Gjb5 gap junction protein, beta 5 multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of GJB5 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GJB5 mRNA
CTD PMID:7586191 PMID:32553695 NCBI chr 5:139,680,670...139,683,588
Ensembl chr 5:139,680,671...139,683,583
JBrowse link
G Gls glutaminase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GLS mRNA CTD PMID:21527772 NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900
JBrowse link
G Gmds GDP-mannose 4, 6-dehydratase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GMDS mRNA CTD PMID:32553695 NCBI chr17:32,095,315...32,621,975
Ensembl chr17:32,095,386...32,621,961
JBrowse link
G Gng12 G protein subunit gamma 12 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GNG12 mRNA CTD PMID:19480007 NCBI chr 4:96,011,118...96,134,767
Ensembl chr 4:96,010,952...96,134,712
JBrowse link
G Gp2 glycoprotein 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GP2 mRNA CTD PMID:19480007 NCBI chr 1:173,797,057...173,812,619
Ensembl chr 1:173,797,057...173,812,619
JBrowse link
G Gpc6 glypican 6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GPC6 mRNA CTD PMID:32553695 NCBI chr15:94,030,218...95,027,883
Ensembl chr15:94,029,884...95,024,006
JBrowse link
G Gphn gephyrin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GPHN mRNA CTD PMID:32553695 NCBI chr 6:96,954,365...97,483,617
Ensembl chr 6:96,892,148...97,483,612
JBrowse link
G Gpr68 G protein-coupled receptor 68 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GPR68 mRNA CTD PMID:19480007 NCBI chr 6:120,135,620...120,166,089
Ensembl chr 6:120,135,436...120,166,089
JBrowse link
G Gprc5a G protein-coupled receptor, class C, group 5, member A multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of GPRC5A mRNA CTD PMID:32553695 NCBI chr 4:167,903,542...167,922,276
Ensembl chr 4:167,903,542...167,922,260
JBrowse link
G Gpt glutamic--pyruvic transaminase affects activity
decreases activity
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene affects the activity of GPT protein
9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GPT protein
Vitamin K affects the reaction [9,10-Dimethyl-1,2-benzanthracene affects the activity of GPT protein]
CTD PMID:32623939 PMID:33063951 NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions
decreases activity
EXP brucine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GPX1 protein] CTD PMID:30027798 NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
JBrowse link
G Gpx2 glutathione peroxidase 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GPX2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GPX2 protein CTD PMID:18056462 NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
JBrowse link
G Gpx3 glutathione peroxidase 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GPX3 mRNA CTD PMID:38307155 NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions
decreases expression
decreases activity
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with argemone oil]] results in decreased activity of GSR protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with sanguinarine]] results in decreased activity of GSR protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of GSR protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with argemone oil] results in decreased activity of GSR protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with sanguinarine] results in decreased activity of GSR protein; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GSR protein]; geraniol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GSR protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein
allyl isothiocyanate inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein]; brucine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein]; zingerone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSR protein]
CTD PMID:20691676 PMID:23033690 PMID:24995432 PMID:25744308 PMID:30027798 More... NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
JBrowse link
G Gss glutathione synthetase increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of GSS mRNA CTD PMID:12376462 NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
JBrowse link
G Gsta1 glutathione S-transferase alpha 1 decreases activity
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSTA1 protein
brucine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased activity of GSTA1 protein]
CTD PMID:30027798 NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
JBrowse link
G Gsta3l1 glutathione S-transferase alpha 3 like 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GSTA3L1 mRNA CTD PMID:19480007 NCBI chr 9:23,619,691...23,628,517
Ensembl chr 9:23,620,010...23,632,333
JBrowse link
G Gstp1 glutathione S-transferase pi 1 affects response to substance
increases expression
decreases expression
multiple interactions
EXP GSTP1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased expression of GSTP1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of GSTP1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of GSTP1 protein
CTD PMID:12097258 PMID:22406437 PMID:24576726 NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
JBrowse link
G Gtdc1 glycosyltransferase-like domain containing 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of GTDC1 mRNA CTD PMID:32553695 NCBI chr 3:28,766,640...29,161,668
Ensembl chr 3:28,766,645...29,162,271
JBrowse link
G Gtse1 G-2 and S-phase expressed 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of GTSE1 mRNA CTD PMID:32553695 NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
JBrowse link
G H19 H19 imprinted maternally expressed transcript affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of H19 mRNA CTD PMID:21785161 NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
JBrowse link
G H1f4 H1.4 linker histone, cluster member multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of H1F4 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of H1F4 protein
CTD PMID:22248470 NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403
JBrowse link
G H2ac18 H2A clustered histone 18 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of H2AC18 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AC18 protein
CTD PMID:22248470 NCBI chr 2:183,808,398...183,808,992 JBrowse link
G H2ax H2A.X variant histone increases expression
increases phosphorylation
multiple interactions
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AX protein
9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of H2AX protein
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of H2AX protein modified form; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AX protein
A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AX protein]
CTD PMID:23969067 PMID:25448685 PMID:32553695 PMID:34510228 NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
Ensembl chr 4:44,671,786...44,673,239
JBrowse link
G Hal histidine ammonia lyase multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with argemone oil]] results in decreased activity of HAL protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with [Tetradecanoylphorbol Acetate co-treated with sanguinarine]] results in decreased activity of HAL protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in decreased activity of HAL protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with argemone oil] results in decreased activity of HAL protein; [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] co-treated with sanguinarine] results in decreased activity of HAL protein CTD PMID:20691676 NCBI chr 7:28,007,449...28,037,701
Ensembl chr 7:28,006,972...28,037,701
JBrowse link
G Has2 hyaluronan synthase 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of HAS2 mRNA CTD PMID:32553695 NCBI chr 7:88,113,326...88,139,337
Ensembl chr 7:88,113,326...88,128,933
JBrowse link
G Hba-a2 hemoglobin alpha, adult chain 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HBA1 mRNA CTD PMID:12376462 NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392
Ensembl chr10:15,307,815...15,338,392
JBrowse link
G Hbb hemoglobin subunit beta multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HBB-B1 mRNA CTD PMID:27891153 NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
JBrowse link
G Hbegf heparin-binding EGF-like growth factor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of HBEGF mRNA CTD PMID:32553695 NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
JBrowse link
G Hdac1 histone deacetylase 1 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein
Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mRNA]; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mRNA]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 mRNA]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of HDAC1 protein]
CTD PMID:24792773 NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
JBrowse link
G Hells helicase, lymphoid specific increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HELLS protein CTD PMID:20025956 NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844
JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha increases activity
affects expression
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased activity of HIF1A protein
9,10-Dimethyl-1,2-benzanthracene affects the expression of HIF1A mRNA
CTD PMID:19502547 PMID:21785161 NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
JBrowse link
G Hist1h2bq histone cluster 1 H2B family member Q multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HIST1H2BQ protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of HIST1H2BQ protein
CTD PMID:22248470 NCBI chr17:41,432,100...41,441,487
Ensembl chr17:41,429,164...41,442,153
Ensembl chr17:41,429,164...41,442,153
Ensembl chr17:41,429,164...41,442,153
JBrowse link
G Hmox1 heme oxygenase 1 decreases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 protein
betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HMOX1 protein]
CTD PMID:12097258 PMID:24995432 PMID:33759307 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
JBrowse link
G Hnrnpa2b1 heterogeneous nuclear ribonucleoprotein A2/B1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of HNRNPA2B1 mRNA CTD PMID:21785161 NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
JBrowse link
G Hnrnpd heterogeneous nuclear ribonucleoprotein D decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HNRNPD protein CTD PMID:38307155 NCBI chr14:9,615,375...9,638,975
Ensembl chr14:9,615,479...9,633,786
JBrowse link
G Hnrnpk heterogeneous nuclear ribonucleoprotein K affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of HNRNPK mRNA CTD PMID:21785161 NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997
JBrowse link
G Hnrnpm heterogeneous nuclear ribonucleoprotein M multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HNRNPM protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of HNRNPM protein
CTD PMID:22248470 NCBI chr 7:14,438,703...14,476,781
Ensembl chr 7:14,438,688...14,476,762
JBrowse link
G Hoxb6 homeo box B6 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HOXB6 mRNA CTD PMID:27891153 NCBI chr10:81,258,726...81,267,458
Ensembl chr10:81,265,056...81,267,449
JBrowse link
G Hp haptoglobin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of HP mRNA CTD PMID:32553695 NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
JBrowse link
G Hras HRas proto-oncogene, GTPase multiple interactions
increases mutagenesis
increases response to substance
ISO 4-octylphenol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]; Estradiol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]
9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene
[9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased expression of HRAS mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide] results in increased mutagenesis of HRAS gene; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate co-treated with mezerein] results in increased expression of HRAS mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of HRAS mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased mutagenesis of HRAS gene; [Ellagic Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Ellagic Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of HRAS gene]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with geraniol] affects the localization of HRAS protein; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of HRAS protein
CTD PMID:1375869 PMID:3115617 PMID:11241758 PMID:11376698 PMID:12117780 More... NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
JBrowse link
G Hrg histidine-rich glycoprotein increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HRG protein CTD PMID:38307155 NCBI chr11:78,054,488...78,069,402
Ensembl chr11:78,054,498...78,069,389
JBrowse link
G Hsp90ab1 heat shock protein 90 alpha family class B member 1 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HSP90AB1 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of HSP90AB1 protein
CTD PMID:22248470 NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of HSPA1A mRNA CTD PMID:27891153 NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of HSPA5 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of HSPA5 protein
CTD PMID:22248470 NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of HSPA8 mRNA CTD PMID:21785161 NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
JBrowse link
G Hspd1 heat shock protein family D (Hsp60) member 1 affects expression
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene affects the expression of HSPD1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HSPD1 mRNA
CTD PMID:12097258 PMID:21785161 NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
JBrowse link
G Hspe1 heat shock protein family E (Hsp10) member 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of HSPE1 mRNA CTD PMID:12097258 NCBI chr 9:56,589,912...56,593,000
Ensembl chr 9:56,589,789...56,593,089
JBrowse link
G Hspg2 heparan sulfate proteoglycan 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of HSPG2 mRNA CTD PMID:21785161 NCBI chr 5:149,677,437...149,778,594
Ensembl chr 5:149,677,476...149,778,594
JBrowse link
G Icam1 intercellular adhesion molecule 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ICAM1 mRNA CTD PMID:12097258 NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
JBrowse link
G Id3 inhibitor of DNA binding 3 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ID3 mRNA CTD PMID:12376462 NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
JBrowse link
G Ier3 immediate early response 3 multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of IER3 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of IER3 mRNA
CTD PMID:32553695 NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
JBrowse link
G Ier5 immediate early response 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of IER5 mRNA CTD PMID:21527772 NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
JBrowse link
G Ift70b intraflagellar transport 70B increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of IFT70B protein CTD PMID:38307155 NCBI chr 3:60,855,809...60,858,380
Ensembl chr 3:60,855,575...60,858,389
JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions ISO IGF1 protein results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Benzoyl Peroxide]; IGF1 protein results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with chrysarobin]; IGF1 protein results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Okadaic Acid]; IGF1 protein results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] CTD PMID:10365914 NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
JBrowse link
G Igf2 insulin-like growth factor 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IGF2 mRNA CTD PMID:19480007 NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
JBrowse link
G Igsf10 immunoglobulin superfamily, member 10 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IGSF10 mRNA CTD PMID:19480007 NCBI chr 2:143,575,710...143,605,044
Ensembl chr 2:143,576,070...143,604,773
JBrowse link
G Il10 interleukin 10 decreases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IL10 protein
citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IL10 protein]
CTD PMID:31926054 NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
JBrowse link
G Il12a interleukin 12A multiple interactions ISO IL12A results in decreased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] CTD PMID:22359662 NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
JBrowse link
G Il12b interleukin 12B multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein] CTD PMID:36416909 NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
JBrowse link
G Il17a interleukin 17A increases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL17A mRNA
Vitamin K inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL17A mRNA]
CTD PMID:33063951 NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
JBrowse link
G Il17ra interleukin 17 receptor A multiple interactions ISO IL17RA results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] CTD PMID:22359662 NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:153,667,534...153,690,174
JBrowse link
G Il17rd interleukin 17 receptor D decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of IL17RD mRNA CTD PMID:32553695 NCBI chr16:2,228,438...2,295,122
Ensembl chr16:2,228,287...2,292,556
JBrowse link
G Il18 interleukin 18 multiple interactions
increases expression
ISO dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL18 mRNA] CTD PMID:33347706 NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
JBrowse link
G Il1a interleukin 1 alpha multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA; [sodium arsenite co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1A protein; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA]]; diacerein inhibits the reaction [[sodium arsenite co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1A protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA]] CTD PMID:35364107 PMID:37352108 NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
JBrowse link
G Il1b interleukin 1 beta increases expression
multiple interactions
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA]]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B mRNA]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA]]
tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1B protein]
CTD PMID:24995432 PMID:33347706 PMID:37352108 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
JBrowse link
G Il1rl1 interleukin 1 receptor-like 1 increases expression
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL1RL1 protein
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IL1RL1 mRNA
CTD PMID:19480007 PMID:20025956 NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
JBrowse link
G Il1rn interleukin 1 receptor antagonist decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of IL1RN mRNA CTD PMID:32553695 NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
JBrowse link
G Il2 interleukin 2 decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IL2 protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL2 protein; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA]]; Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL2 protein]
CTD PMID:8931739 PMID:25770929 PMID:37352108 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
JBrowse link
G Il33 interleukin 33 increases expression EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL33 mRNA CTD PMID:19480007 PMID:27869817 NCBI chr 1:227,701,964...227,736,374
Ensembl chr 1:227,721,435...227,736,373
JBrowse link
G Il4r interleukin 4 receptor multiple interactions
increases expression
ISO AHR mRNA promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL4RA] CTD PMID:27869817 NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter]]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to IL6 promoter]]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 protein; [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of IL6 mRNA; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]; [Glucaric Acid co-treated with Ursolic Acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of IL6 protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA]]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 mRNA]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 protein]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased secretion of IL6 protein]; Glucaric Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA]]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]; Ursolic Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of IL6 mRNA]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of IL6 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 protein
citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of IL6 protein]
CTD PMID:14678569 PMID:20043298 PMID:23835587 PMID:24995432 PMID:27891153 More... NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
JBrowse link
G Immp2l inner mitochondrial membrane peptidase subunit 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of IMMP2L mRNA CTD PMID:32553695 NCBI chr 6:58,070,035...58,970,165
Ensembl chr 6:58,070,283...58,969,840
JBrowse link
G Impa1 inositol monophosphatase 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IMPA1 protein CTD PMID:38307155 NCBI chr 2:91,462,781...91,484,057
Ensembl chr 2:91,462,799...91,484,313
JBrowse link
G Inhbb inhibin subunit beta B increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of INHBB mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of INHBB mRNA
CTD PMID:32553695 NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832
JBrowse link
G Insig1 insulin induced gene 1 affects expression
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene affects the expression of INSIG1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of INSIG1 mRNA
CTD PMID:12376462 PMID:21785161 NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
JBrowse link
G Isg15 ISG15 ubiquitin-like modifier increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ISG15 mRNA CTD PMID:21527772 NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
JBrowse link
G Itgb3 integrin subunit beta 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ITGB3 mRNA CTD PMID:32553695 NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
JBrowse link
G Itgb6 integrin subunit beta 6 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ITGB6 mRNA CTD PMID:19480007 NCBI chr 3:45,046,295...45,170,532
Ensembl chr 3:45,048,044...45,121,671
JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor, type 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of ITPR1 mRNA CTD PMID:32553695 NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
JBrowse link
G Ivd isovaleryl-CoA dehydrogenase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of IVD protein CTD PMID:38307155 NCBI chr 3:105,851,710...105,872,144
Ensembl chr 3:105,851,683...105,872,575
JBrowse link
G Ivns1abp influenza virus NS1A binding protein affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of IVNS1ABP mRNA CTD PMID:21785161 NCBI chr13:63,427,040...63,446,701
Ensembl chr13:63,427,041...63,446,701
JBrowse link
G Jchain joining chain of multimeric IgA and IgM decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of JCHAIN mRNA CTD PMID:19480007 NCBI chr14:19,538,927...19,547,023
Ensembl chr14:19,538,952...19,546,298
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased expression of JUN protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA; [Glucaric Acid co-treated with Resveratrol] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]; [Glucaric Acid co-treated with Ursolic Acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA]]; Glucaric Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA]]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]; Ursolic Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of JUN protein modified form
CTD PMID:20025956 PMID:22406437 PMID:23835587 PMID:37352108 NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
JBrowse link
G Keap1 Kelch-like ECH-associated protein 1 increases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 protein
betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of KEAP1 protein]
CTD PMID:24995432 PMID:33759307 NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
JBrowse link
G Kif1a kinesin family member 1A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KIF1A mRNA CTD PMID:21527772 NCBI chr 9:93,563,033...93,647,412
Ensembl chr 9:93,563,045...93,647,480
JBrowse link
G Kif21a kinesin family member 21A increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of KIF21A mRNA CTD PMID:32553695 NCBI chr 7:122,062,523...122,179,051
Ensembl chr 7:122,062,537...122,178,999
JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of KIT protein CTD PMID:24576726 NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
JBrowse link
G Kitlg KIT ligand increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KITLG mRNA CTD PMID:24576726 NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
JBrowse link
G Klf10 KLF transcription factor 10 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of KLF10 mRNA CTD PMID:12097258 NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
JBrowse link
G Klf4 KLF transcription factor 4 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of KLF4 mRNA CTD PMID:32553695 NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
JBrowse link
G Klhl29 kelch-like family member 29 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of KLHL29 mRNA CTD PMID:32553695 NCBI chr 6:28,086,489...28,390,647
Ensembl chr 6:28,086,489...28,390,647
JBrowse link
G Kmt2c lysine methyltransferase 2C decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of KMT2C mRNA CTD PMID:32553695 NCBI chr 4:9,620,638...9,834,787
Ensembl chr 4:9,609,627...9,833,539
JBrowse link
G Kng1 kininogen 1 multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of KNG1 protein CTD PMID:22248470 NCBI chr11:77,812,757...77,835,555
Ensembl chr11:77,812,752...77,835,555
JBrowse link
G Kng2 kininogen 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KNG2 mRNA CTD PMID:19480007 NCBI chr11:77,913,876...77,936,247
Ensembl chr11:77,909,612...78,002,971
JBrowse link
G Krt1 keratin 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT1 protein CTD PMID:38307155 NCBI chr 7:132,976,618...132,981,844
Ensembl chr 7:132,976,620...132,981,844
JBrowse link
G Krt10 keratin 10 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT10 protein CTD PMID:38307155 NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,338,706...84,343,701
JBrowse link
G Krt13 keratin 13 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT13 protein CTD PMID:38307155 NCBI chr10:85,051,887...85,056,099
Ensembl chr10:85,051,889...85,056,084
JBrowse link
G Krt19 keratin 19 increases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT19 protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of KRT19 protein
CTD PMID:22248470 NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
JBrowse link
G Krt5 keratin 5 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of KRT5 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT5 mRNA
CTD PMID:12376462 PMID:19480007 PMID:22248470 NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850
JBrowse link
G Krt78 keratin 78 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of KRT78 protein CTD PMID:38307155 NCBI chr 7:133,074,193...133,081,536
Ensembl chr 7:133,074,215...133,082,021
JBrowse link
G Krt8 keratin 8 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of KRT8 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT8 protein
CTD PMID:22248470 NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
JBrowse link
G Krt80 keratin 80 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT80 mRNA CTD PMID:21527772 NCBI chr 7:132,463,216...132,485,134
Ensembl chr 7:132,463,218...132,485,508
JBrowse link
G Lamc2 laminin subunit gamma 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LAMC2 mRNA CTD PMID:21527772 NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
JBrowse link
G Lamtor2 late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LAMTOR2 protein CTD PMID:38307155 NCBI chr 2:174,008,556...174,011,950
Ensembl chr 2:174,008,548...174,013,013
JBrowse link
G Large1 LARGE xylosyl- and glucuronyltransferase 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of LARGE mRNA CTD PMID:32553695 NCBI chr19:11,603,129...12,048,930
Ensembl chr19:11,603,129...12,048,930
JBrowse link
G Lck LCK proto-oncogene, Src family tyrosine kinase increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LCK mRNA CTD PMID:19480007 NCBI chr 5:141,888,318...141,916,945
Ensembl chr 5:141,888,326...141,903,794
JBrowse link
G Lgals3 galectin 3 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of LGALS3 mRNA CTD PMID:21785161 NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
JBrowse link
G Lgals7 galectin 7 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LGALS7 mRNA CTD PMID:21527772 NCBI chr 1:84,148,612...84,152,016
Ensembl chr 1:84,150,252...84,152,015
JBrowse link
G Lgr5 leucine rich repeat containing G protein coupled receptor 5 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LGR5 mRNA CTD PMID:36863560 NCBI chr 7:51,087,059...51,221,882
Ensembl chr 7:51,088,239...51,222,446
JBrowse link
G Limd1 LIM domain containing 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LIMD1 mRNA CTD PMID:19480007 NCBI chr 8:123,121,363...123,168,476
Ensembl chr 8:123,122,460...123,167,714
JBrowse link
G Lin7a lin-7 homolog A, crumbs cell polarity complex component decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LIN7A mRNA CTD PMID:12376462 NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
JBrowse link
G Lmna lamin A/C multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of LMNA protein CTD PMID:22248470 NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
JBrowse link
G Lpl lipoprotein lipase decreases expression
multiple interactions
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LPL mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of LPL mRNA
CTD PMID:12376462 PMID:32553695 NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
JBrowse link
G Lrrc59 leucine rich repeat containing 59 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LRRC59 protein CTD PMID:38307155 NCBI chr10:79,572,295...79,586,953
Ensembl chr10:79,572,317...79,602,533
JBrowse link
G Lsm4 LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LSM4 protein CTD PMID:38307155 NCBI chr16:18,755,481...18,761,106
Ensembl chr16:18,755,484...18,760,926
JBrowse link
G Lsm6 LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LSM6 protein CTD PMID:38307155 NCBI chr19:29,098,254...29,112,858
Ensembl chr13:42,114,032...42,116,484
Ensembl chr19:42,114,032...42,116,484
JBrowse link
G Lsr lipolysis stimulated lipoprotein receptor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LSR mRNA CTD PMID:12376462 NCBI chr 1:86,185,769...86,201,952
Ensembl chr 1:86,186,431...86,201,952
JBrowse link
G Lss lanosterol synthase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of LSS mRNA CTD PMID:32553695 NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,092,774...12,118,762
JBrowse link
G Ltc4s leukotriene C4 synthase increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LTC4S mRNA CTD PMID:19480007 NCBI chr10:34,560,476...34,562,790
Ensembl chr10:34,560,360...34,562,651
JBrowse link
G Ly6e lymphocyte antigen 6 family member E affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of LY6E mRNA CTD PMID:21785161 NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
JBrowse link
G Lypd1 Ly6/Plaur domain containing 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of LYPD1 mRNA CTD PMID:19480007 NCBI chr13:37,326,459...37,368,515
Ensembl chr13:37,326,464...37,368,493
JBrowse link
G Lyrm4 LYR motif containing 4 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of LYRM4 mRNA CTD PMID:32553695 NCBI chr17:28,746,457...28,861,849
Ensembl chr17:28,746,469...28,861,750
JBrowse link
G Lyve1 lymphatic vessel endothelial hyaluronan receptor 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of LYVE1 mRNA CTD PMID:19480007 NCBI chr 1:164,962,872...164,976,309
Ensembl chr 1:164,962,872...164,976,309
JBrowse link
G Maea macrophage erythroblast attacher, E3 ubiquitin ligase affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of MAEA mRNA CTD PMID:21785161 NCBI chr14:77,357,261...77,390,683
Ensembl chr14:77,357,264...77,390,671
JBrowse link
G Mafb MAF bZIP transcription factor B decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MAFB mRNA CTD PMID:19480007 NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
JBrowse link
G Magi1 membrane associated guanylate kinase, WW and PDZ domain containing 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of MAGI1 mRNA CTD PMID:32553695 NCBI chr 4:126,205,663...126,811,354
Ensembl chr 4:126,206,816...126,811,691
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases expression
ISO
EXP
[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased phosphorylation of MAPK1 protein; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased phosphorylation of MAPK1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of MAPK1 protein
CTD PMID:22760862 PMID:36863560 NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases expression
ISO
EXP
[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased phosphorylation of MAPK3 protein; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased phosphorylation of MAPK3 protein]
betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MAPK3 mRNA]
CTD PMID:22760862 PMID:33759307 NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MAPK8 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MAPK8 protein
betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MAPK8 mRNA]
CTD PMID:33759307 PMID:36863560 NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
JBrowse link
G Mat2a methionine adenosyltransferase 2A affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of MAT2A mRNA CTD PMID:21785161 NCBI chr 4:104,489,877...104,495,447
Ensembl chr 4:104,488,466...104,495,493
JBrowse link
G Mcm3 minichromosome maintenance complex component 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MCM3 protein CTD PMID:20025956 NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314
JBrowse link
G Mdh2 malate dehydrogenase 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDH2 mRNA CTD PMID:12376462 NCBI chr12:20,894,269...20,907,225
Ensembl chr12:20,894,262...20,907,271
JBrowse link
G Mdm2 MDM2 proto-oncogene increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of MDM2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA
[epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]
CTD PMID:23717041 PMID:32553695 NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
JBrowse link
G Megf6 multiple EGF-like-domains 6 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MEGF6 mRNA CTD PMID:19480007 NCBI chr 5:164,738,272...164,839,142
Ensembl chr 5:164,738,352...164,839,139
JBrowse link
G Mgarp mitochondria-localized glutamic acid-rich protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MGARP mRNA CTD PMID:19480007 NCBI chr 2:135,431,283...135,439,425
Ensembl chr 2:135,431,283...135,439,612
JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase multiple interactions ISO MGMT protein results in decreased susceptibility to [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] CTD PMID:12663516 NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
JBrowse link
G Mgp matrix Gla protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MGP mRNA CTD PMID:12376462 NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
JBrowse link
G Mif macrophage migration inhibitory factor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MIF mRNA CTD PMID:12376462 NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
Ensembl chr 4:12,790,902...12,799,504
JBrowse link
G Mir203-2 microRNA 203-2 affects expression
multiple interactions
increases methylation
ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of MIR203 mRNA
Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the expression of MIR203 mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of MIR203 promoter]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the expression of MIR203 mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of MIR203 promoter]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the expression of MIR203 mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased methylation of MIR203 promoter]
CTD PMID:24792773 NCBI chr 6:131,199,542...131,199,656
Ensembl chr 6:131,199,542...131,199,656
JBrowse link
G Misp3 MISP family member 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MISP3 mRNA CTD PMID:19480007 NCBI chr19:24,139,998...24,142,006
Ensembl chr19:24,140,033...24,142,631
JBrowse link
G Mki67 marker of proliferation Ki-67 multiple interactions
increases expression
EXP 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of MKI67 mRNA]; [Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of MKI67 protein; [Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]; Plant Preparations inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of MKI67 mRNA]] CTD PMID:16891317 PMID:26945725 PMID:34896434 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
JBrowse link
G Mlf2 myeloid leukemia factor 2 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of MLF2 mRNA CTD PMID:21785161 NCBI chr 4:157,739,651...157,744,325
Ensembl chr 4:157,728,756...157,744,317
JBrowse link
G Mme membrane metallo-endopeptidase decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MME mRNA CTD PMID:19480007 NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
JBrowse link
G Mmp12 matrix metallopeptidase 12 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP12 mRNA CTD PMID:19480007 NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
JBrowse link
G Mmp13 matrix metallopeptidase 13 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP13 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP13 protein CTD PMID:19480007 NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
JBrowse link
G Mmp14 matrix metallopeptidase 14 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MMP14 mRNA CTD PMID:19480007 NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP2 protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP2 protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP2 protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA]] CTD PMID:37352108 NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
JBrowse link
G Mmp7 matrix metallopeptidase 7 decreases expression
increases expression
EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MMP7 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP7 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP7 protein
CTD PMID:19480007 NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
JBrowse link
G Mmp9 matrix metallopeptidase 9 affects expression
multiple interactions
increases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene affects the expression of MMP9 mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA; [sodium arsenite results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate]] which results in increased expression of MMP9 protein; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA]]
[9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride co-treated with Fluoxetine] affects the expression of MMP9 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Raloxifene Hydrochloride] affects the expression of MMP9 protein; [Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein]; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MMP9 protein]
CTD PMID:12208745 PMID:21785161 PMID:31332895 PMID:34896434 PMID:35364107 More... NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
JBrowse link
G Mpo myeloperoxidase multiple interactions
increases activity
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with cumene hydroperoxide] results in increased activity of MPO protein
9,10-Dimethyl-1,2-benzanthracene results in increased activity of MPO protein
CTD PMID:14972014 PMID:32623939 NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
JBrowse link
G Mr1 major histocompatibility complex, class I-related increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MR1 mRNA CTD PMID:21527772 NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
JBrowse link
G Msra methionine sulfoxide reductase A decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of MSRA mRNA CTD PMID:32553695 NCBI chr15:38,363,459...38,677,406
Ensembl chr15:38,351,445...38,676,585
JBrowse link
G Mt-co1 mitochondrially encoded cytochrome c oxidase I decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of COX1 mRNA CTD PMID:12376462 NCBI chr MT:5,323...6,867
NCBI chr MT:5,323...6,867
NCBI chr MT:5,323...6,867
NCBI chr MT:5,323...6,867
NCBI chr MT:5,323...6,867
NCBI chr MT:5,323...6,867
NCBI chr MT:5,323...6,867
NCBI chr MT:5,323...6,867
NCBI chr MT:5,323...6,867
NCBI chr MT:5,323...6,867
NCBI chr MT:5,323...6,867
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
JBrowse link
G Mt1 metallothionein 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MT1 mRNA CTD PMID:19480007 NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
Ensembl chr17:10,826,032...10,827,049
Ensembl chr  X:10,826,032...10,827,049
JBrowse link
G Mto1 mitochondrial tRNA translation optimization 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MTO1 mRNA CTD PMID:19480007 NCBI chr 8:79,309,681...79,335,231
Ensembl chr 8:79,309,982...79,335,231
JBrowse link
G Mtor mechanistic target of rapamycin kinase decreases expression
increases expression
ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MTOR protein modified form
9,10-Dimethyl-1,2-benzanthracene results in increased expression of MTOR protein modified form
CTD PMID:21785161 NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
JBrowse link
G Muc1 mucin 1, cell surface associated decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MUC1 mRNA CTD PMID:19480007 NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
JBrowse link
G Myb MYB proto-oncogene, transcription factor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYB mRNA CTD PMID:36863560 NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions
increases expression
ISO [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC protein; Butyric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA]; Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA]]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC protein]; Glucaric Acid affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA]; Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein]; Niacinamide affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA]; Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA]]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of MYC mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYC protein
CTD PMID:20537511 PMID:24792773 PMID:29663660 PMID:32553695 PMID:37352108 NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
JBrowse link
G Myh9 myosin, heavy chain 9 increases expression
multiple interactions
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MYH9 protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of MYH9 protein
CTD PMID:22248470 NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
JBrowse link
G Mylk myosin light chain kinase decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of MYLK mRNA CTD PMID:32553695 NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
JBrowse link
G Myod1 myogenic differentiation 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of MYOD1 mRNA CTD PMID:36863560 NCBI chr 1:96,884,864...96,887,574
Ensembl chr 1:96,884,948...96,887,554
JBrowse link
G N4bp1 Nedd4 binding protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of N4BP1 mRNA CTD PMID:32553695 NCBI chr19:20,222,811...20,273,570
Ensembl chr19:20,222,776...20,273,570
JBrowse link
G Ncald neurocalcin delta decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of NCALD mRNA CTD PMID:32553695 NCBI chr 7:68,532,671...68,964,740
Ensembl chr 7:68,534,421...68,964,496
JBrowse link
G Ncam1 neural cell adhesion molecule 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of NCAM1 mRNA CTD PMID:32553695 NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014
JBrowse link
G Ncmap noncompact myelin associated protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NCMAP mRNA CTD PMID:19480007 NCBI chr 5:147,608,042...147,623,266
Ensembl chr 5:147,610,677...147,618,775
JBrowse link
G Ndufb8 NADH:ubiquinone oxidoreductase subunit B8 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NDUFB8 protein CTD PMID:38307155 NCBI chr 1:243,408,656...243,413,715
Ensembl chr 1:243,408,619...243,413,817
JBrowse link
G Nell1 neural EGFL like 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NELL1 mRNA CTD PMID:19480007 NCBI chr 1:99,709,305...100,573,872
Ensembl chr 1:99,709,793...100,573,860
JBrowse link
G Nes nestin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NES protein CTD PMID:38307155 NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
JBrowse link
G Neto2 neuropilin and tolloid like 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NETO2 mRNA CTD PMID:21527772 NCBI chr19:21,344,299...21,415,524
Ensembl chr19:21,344,289...21,417,023
JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases expression
multiple interactions
increases activity
decreases expression
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of NFE2L2 protein
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of NFE2L2 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NFE2L2 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased activity of NFE2L2 protein
betulin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFE2L2 protein
CTD PMID:22406437 PMID:24995432 PMID:30114225 PMID:32553695 PMID:33759307 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter]]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to IL6 promoter]]; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKB1 protein; [Ursolic Acid co-treated with Glucaric Acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKB1 protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA]] CTD PMID:14678569 PMID:23835587 PMID:37352108 NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions
increases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of and results in increased phosphorylation of NFKBIA protein; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKBIA protein modified form; dieckol affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NFKBIA protein]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased phosphorylation of NFKBIA protein]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NFKBIA protein modified form]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of NFKBIA mRNA
citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NFKBIA mRNA]
CTD PMID:20043298 PMID:31926054 PMID:33347706 NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
JBrowse link
G Nid1 nidogen 1 affects expression
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene affects the expression of NID1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NID1 mRNA
CTD PMID:19480007 PMID:21785161 NCBI chr17:86,085,133...86,158,272
Ensembl chr17:86,085,077...86,158,267
JBrowse link
G Nipsnap2 nipsnap homolog 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NIPSNAP2 mRNA CTD PMID:21785161 NCBI chr12:26,906,068...26,944,201
Ensembl chr12:26,911,723...26,944,166
JBrowse link
G Nkg7 natural killer cell granule protein 7 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NKG7 mRNA CTD PMID:19480007 NCBI chr 1:93,844,748...93,845,975
Ensembl chr 1:93,844,902...93,845,983
JBrowse link
G Nlrp5 NLR family, pyrin domain containing 5 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of NLRP5 mRNA CTD PMID:21785161 NCBI chr 1:67,778,037...67,810,941
Ensembl chr 1:67,777,948...68,023,736
JBrowse link
G Nos2 nitric oxide synthase 2 increases expression
multiple interactions
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 protein
[Maxepa co-treated with Calcitriol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 mRNA]; citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NOS2 protein]
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NOS2 protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of NOS2 protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein]]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of NOS2 protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein]]
CTD PMID:20043298 PMID:20599847 PMID:24995432 PMID:31926054 PMID:32662567 More... NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
JBrowse link
G Notch1 notch receptor 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NOTCH1 mRNA CTD PMID:32553695 NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
JBrowse link
G Notch3 notch receptor 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NOTCH3 mRNA CTD PMID:32553695 NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025
JBrowse link
G Nppc natriuretic peptide C multiple interactions ISO Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP2 protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of TNF mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of VEGFA mRNA]]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of TNF mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of VEGFA mRNA]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP2 protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of and results in increased activity of MMP9 protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of CRP protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of FOS mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1A mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL1B mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL2 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of IL6 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of JUN mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP2 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MMP9 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of MYC mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NFKB1 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of NOS2 protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of TNF mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of VEGFA mRNA]] CTD PMID:37352108 NCBI chr 9:87,320,051...87,324,251
Ensembl chr 9:87,320,051...87,324,251
JBrowse link
G Npr3 natriuretic peptide receptor 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of NPR3 mRNA CTD PMID:32553695 NCBI chr 2:60,865,483...60,933,432
Ensembl chr 2:60,870,594...60,932,955
JBrowse link
G Nptx1 neuronal pentraxin 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NPTX1 mRNA CTD PMID:19480007 NCBI chr10:104,811,107...104,820,358
Ensembl chr10:104,811,403...104,820,367
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases activity
increases expression
multiple interactions
decreases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene results in increased activity of NQO1 protein
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NQO1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of NQO1 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of NQO1 protein; Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of and results in increased activity of NQO1 protein]; Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of NQO1 mRNA]
acetylsalicylic acid lysinate promotes the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of NQO1 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NQO1 mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NQO1 protein]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NQO1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NQO1 protein
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of NQO1 mRNA; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased activity of NQO1 protein]
CTD PMID:18678235 PMID:18694800 PMID:24995432 PMID:25697376 PMID:32553695 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
JBrowse link
G Nr2f1 nuclear receptor subfamily 2, group F, member 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of NR2F1 mRNA CTD PMID:19480007 NCBI chr 2:8,040,375...8,050,123
Ensembl chr 2:8,040,377...8,050,123
JBrowse link
G Nr4a1 nuclear receptor subfamily 4, group A, member 1 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of NR4A1 mRNA CTD PMID:27891153 NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
JBrowse link
G Nsdhl NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of NSDHL mRNA CTD PMID:21785161 NCBI chr  X:150,775,034...150,807,161
Ensembl chr  X:150,775,080...150,807,142
JBrowse link
G Nsmf NMDA receptor synaptonuclear signaling and neuronal migration factor increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NSMF mRNA CTD PMID:12376462 NCBI chr 3:7,861,846...7,870,615
Ensembl chr 3:7,861,872...7,870,614
JBrowse link
G Ntf3 neurotrophin 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of NTF3 mRNA CTD PMID:19480007 NCBI chr 4:158,914,984...158,984,453
Ensembl chr 4:158,914,957...158,984,596
JBrowse link
G Nubpl NUBP iron-sulfur cluster assembly factor like decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of NUBPL mRNA CTD PMID:32553695 NCBI chr 6:69,559,278...69,781,254
Ensembl chr 6:69,559,291...69,781,253
JBrowse link
G Nusap1 nucleolar and spindle associated protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NUSAP1 mRNA CTD PMID:32553695 NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624
JBrowse link
G Ogg1 8-oxoguanine DNA glycosylase increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of OGG1 mRNA
Metformin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of OGG1 mRNA]
CTD PMID:25697376 NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
JBrowse link
G Ogn osteoglycin decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of OGN mRNA CTD PMID:19480007 NCBI chr17:15,032,069...15,052,626
Ensembl chr17:15,032,069...15,052,739
JBrowse link
G Olfml3 olfactomedin-like 3 multiple interactions EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of OLFML3 protein CTD PMID:22248470 NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:191,244,221...191,247,050
JBrowse link
G Orm1 orosomucoid 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ORM1 protein CTD PMID:20025956 NCBI chr 5:76,766,637...76,776,149
Ensembl chr 5:76,772,941...76,776,154
JBrowse link
G Otor otoraplin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of OTOR mRNA CTD PMID:32553695 NCBI chr 3:130,415,339...130,418,601
Ensembl chr 3:130,415,339...130,418,601
JBrowse link
G Pabpc1 poly(A) binding protein, cytoplasmic 1 affects expression
multiple interactions
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene affects the expression of PABPC1 mRNA
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of PABPC1 protein
CTD PMID:21785161 PMID:22248470 NCBI chr 7:67,777,438...67,789,731
Ensembl chr 7:67,777,381...67,789,744
JBrowse link
G Padi4 peptidyl arginine deiminase 4 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PADI4 mRNA CTD PMID:12376462 NCBI chr 5:153,041,351...153,074,412
Ensembl chr 5:153,041,352...153,074,362
JBrowse link
G Papss2 3'-phosphoadenosine 5'-phosphosulfate synthase 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PAPSS2 mRNA CTD PMID:19480007 NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
JBrowse link
G Pard6g par-6 family cell polarity regulator gamma increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PARD6G mRNA CTD PMID:32553695 NCBI chr18:73,497,992...73,565,048
Ensembl chr18:73,498,021...73,565,029
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 decreases expression
multiple interactions
increases expression
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PARP1 mRNA
9,10-Dimethyl-1,2-benzanthracene promotes the reaction [A gene mutant form results in increased expression of PARP1 mRNA]; 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [A gene mutant form results in increased expression of PARP1 protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PARP1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PARP1 protein
CTD PMID:23969067 PMID:25448685 NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
JBrowse link
G Pcca propionyl-CoA carboxylase subunit alpha decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PCCA mRNA CTD PMID:32553695 NCBI chr15:99,627,955...99,969,555
Ensembl chr15:99,627,982...99,968,266
JBrowse link
G Pcdh18 protocadherin 18 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PCDH18 mRNA CTD PMID:32553695 NCBI chr 2:133,831,996...133,845,992
Ensembl chr 2:133,832,001...133,845,883
JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions
increases expression
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA protein; [Glucaric Acid co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA mRNA]; [Resveratrol co-treated with Ellagic Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA mRNA]; [Resveratrol co-treated with Plant Extracts] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA mRNA]; [sodium arsenite results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate]] which results in increased expression of PCNA protein; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA mRNA]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein]]; Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PCNA protein]; Masoprocol affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PCNA protein]]; Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein]; Tacrolimus affects the reaction [Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein]]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA protein
mithramycin A inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA protein]
9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of PCNA mRNA]; Plant Preparations inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of PCNA mRNA]]; Taurine inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCNA protein]
CTD PMID:20043298 PMID:20103723 PMID:22248470 PMID:25770929 PMID:26945725 More... NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
JBrowse link
G Pcp4 Purkinje cell protein 4 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCP4 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PCP4 protein CTD PMID:19480007 NCBI chr11:35,759,711...35,861,725
Ensembl chr11:35,800,713...35,861,725
JBrowse link
G Pcsk6 proprotein convertase subtilisin/kexin type 6 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PCSK6 mRNA CTD PMID:32553695 NCBI chr 1:119,428,978...119,627,626
Ensembl chr 1:119,429,265...119,627,596
JBrowse link
G Pde1a phosphodiesterase 1A decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PDE1A mRNA CTD PMID:32553695 NCBI chr 3:64,745,140...65,025,178
Ensembl chr 3:64,747,269...65,024,874
JBrowse link
G Pde4dip phosphodiesterase 4D interacting protein decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PDE4DIP mRNA CTD PMID:32553695 NCBI chr 2:185,293,236...185,490,100
Ensembl chr 2:185,293,214...185,468,379
JBrowse link
G Pdgfa platelet derived growth factor subunit A increases expression
increases expression
EXP
IEP
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PDGFA mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PDGFA protein
DMBA increases expression of Pdgfa mRNA and protein in rat mammary gland
CTD
RGD
PMID:12376462 PMID:12376462 RGD:2292404 NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
JBrowse link
G Pdia3 protein disulfide isomerase family A, member 3 multiple interactions
increases expression
EXP [9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of PDIA3 protein
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PDIA3 protein
CTD PMID:22248470 NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
JBrowse link
G Pdpk1 3-phosphoinositide dependent protein kinase-1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PDK mRNA CTD PMID:32553695 NCBI chr10:13,105,435...13,182,664
Ensembl chr10:13,105,498...13,174,623
JBrowse link
G Pebp1 phosphatidylethanolamine binding protein 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PEBP1 mRNA CTD PMID:12376462 NCBI chr12:39,302,864...39,307,064
Ensembl chr12:39,302,840...39,307,862
JBrowse link
G Penk proenkephalin decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PENK mRNA CTD PMID:19480007 NCBI chr 5:17,183,799...17,189,160
Ensembl chr 5:17,183,806...17,189,129
JBrowse link
G Pfkm phosphofructokinase, muscle increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PFKM mRNA CTD PMID:19502547 NCBI chr 7:129,221,679...129,259,192
Ensembl chr 7:129,221,653...129,259,192
JBrowse link
G Pgd phosphogluconate dehydrogenase multiple interactions ISO [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PGD mRNA CTD PMID:32553695 NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
JBrowse link
G Pglyrp1 peptidoglycan recognition protein 1 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of PGLYRP1 mRNA CTD PMID:21785161 NCBI chr 1:78,531,815...78,537,001
Ensembl chr 1:78,531,815...78,537,001
JBrowse link
G Phb1 prohibitin 1 increases expression
increases expression
EXP
IEP
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PHB1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PHB1 protein
DMBA increases expression of Phb1 mRNA and protein in rat mammary gland
CTD
RGD
PMID:12376462 PMID:12376462 RGD:2292404 NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
JBrowse link
G Phex phosphate regulating endopeptidase X-linked increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PHEX protein CTD PMID:20025956 NCBI chr  X:37,607,553...37,856,183
Ensembl chr  X:37,610,760...37,854,469
JBrowse link
G Phlda1 pleckstrin homology-like domain, family A, member 1 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PHLDA1 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PHLDA1 mRNA
CTD PMID:32553695 NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
JBrowse link
G Phlda3 pleckstrin homology-like domain, family A, member 3 affects expression
multiple interactions
increases expression
ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of PHLDA3 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PHLDA3 mRNA
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PHLDA3 mRNA
CTD PMID:21785161 PMID:32553695 NCBI chr13:47,193,250...47,196,335
Ensembl chr13:47,193,086...47,196,335
JBrowse link
G Piga phosphatidylinositol glycan anchor biosynthesis, class A multiple interactions
increases mutagenesis
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of and results in decreased activity of PIGA protein; [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein
9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of PIGA; 9,10-Dimethyl-1,2-benzanthracene results in increased mutagenesis of PIGA gene
CTD PMID:19965957 PMID:20202993 PMID:22923490 NCBI chr  X:30,043,033...30,055,861
Ensembl chr  X:30,042,343...30,055,804
JBrowse link
G Pik3r5 phosphoinositide-3-kinase, regulatory subunit 5 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PIK3R5 protein CTD PMID:20025956 NCBI chr10:53,132,585...53,200,663
Ensembl chr10:53,132,603...53,199,374
JBrowse link
G Pitx1 paired-like homeodomain 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PITX1 mRNA CTD PMID:19480007 NCBI chr17:8,794,134...8,800,292
Ensembl chr17:8,794,134...8,800,291
JBrowse link
G Plau plasminogen activator, urokinase increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PLAU mRNA CTD PMID:21527772 NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
JBrowse link
G Plg plasminogen decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PLG protein CTD PMID:38307155 NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
JBrowse link
G Plk2 polo-like kinase 2 increases expression
increases expression
EXP
IEP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PLK2 mRNA
DMBA increases expression of Plk2 mRNA and protein in rat mammary gland
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PLK2 mRNA
CTD
RGD
PMID:12376462 PMID:32553695 PMID:12376462 RGD:2292404 NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
JBrowse link
G Plxna2 plexin A2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PLXNA2 mRNA CTD PMID:32553695 NCBI chr13:106,163,103...106,358,979
Ensembl chr13:106,163,103...106,358,979
JBrowse link
G Pnisr PNN interacting serine and arginine rich protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PNISR mRNA CTD PMID:19480007 NCBI chr 5:35,395,965...35,422,852
Ensembl chr 5:35,395,965...35,422,844
JBrowse link
G Polm DNA polymerase mu increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of POLM mRNA CTD PMID:19480007 NCBI chr14:80,707,075...80,716,677
Ensembl chr14:80,706,345...80,717,086
JBrowse link
G Polr2a RNA polymerase II subunit A multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of POLR2A mRNA CTD PMID:27891153 NCBI chr10:54,452,438...54,478,486
Ensembl chr10:54,452,441...54,478,455
JBrowse link
G Pomc proopiomelanocortin multiple interactions EXP POMC protein promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene] CTD PMID:7588239 NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
JBrowse link
G Por cytochrome p450 oxidoreductase multiple interactions
decreases abundance
ISO POR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein]
POR protein results in decreased abundance of 9,10-Dimethyl-1,2-benzanthracene
CTD PMID:22595614 NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene binds to and results in increased activity of PPARG protein CTD PMID:33049310 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
JBrowse link
G Ppfibp2 PPFIA binding protein 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PPFIBP2 mRNA CTD PMID:32553695 NCBI chr 1:161,504,774...161,687,339
Ensembl chr 1:161,504,890...161,655,212
JBrowse link
G Ppm1d protein phosphatase, Mg2+/Mn2+ dependent, 1D increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PPM1D mRNA CTD PMID:32553695 NCBI chr10:70,172,603...70,208,607
Ensembl chr10:70,172,603...70,208,607
JBrowse link
G Ppm1l protein phosphatase, Mg2+/Mn2+ dependent, 1L decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PPM1L mRNA CTD PMID:32553695 NCBI chr 2:153,566,653...153,839,434
Ensembl chr 2:153,566,653...153,839,434
JBrowse link
G Ppp1cb protein phosphatase 1 catalytic subunit beta affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of PPP1CB mRNA CTD PMID:21785161 NCBI chr 6:23,958,813...23,992,841
Ensembl chr 6:23,960,998...23,992,824
JBrowse link
G Ppp1r3c protein phosphatase 1, regulatory subunit 3C decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PPP1R3C mRNA CTD PMID:32553695 NCBI chr 1:234,460,958...234,465,961
Ensembl chr 1:234,460,652...234,465,961
JBrowse link
G Ppp2r1b protein phosphatase 2 scaffold subunit A beta decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PPP2R1B mRNA CTD PMID:19502547 NCBI chr 8:51,195,860...51,228,442
Ensembl chr 8:51,186,717...51,228,485
JBrowse link
G Ppp2r2b protein phosphatase 2, regulatory subunit B, beta increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PPP2R2B mRNA CTD PMID:19480007 NCBI chr18:34,653,716...35,080,889
Ensembl chr18:34,653,721...35,081,025
JBrowse link
G Prdm1 PR/SET domain 1 decreases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PRDM1 mRNA
AHR protein affects the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA]; alpha-naphthoflavone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRDM1 mRNA]
CTD PMID:20562217 NCBI chr20:47,959,858...47,981,488
Ensembl chr20:47,959,858...47,981,488
JBrowse link
G Prdm6 PR/SET domain 6 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PRDM6 mRNA CTD PMID:19480007 NCBI chr18:46,904,115...47,008,482
Ensembl chr18:46,904,127...47,007,823
JBrowse link
G Prdx2 peroxiredoxin 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PRDX2 protein CTD PMID:20045496 NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
JBrowse link
G Prkca protein kinase C, alpha multiple interactions
increases expression
EXP Ghee inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PRKCA mRNA] CTD PMID:21088903 NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
JBrowse link
G Prkcb protein kinase C, beta multiple interactions ISO PRKCB protein inhibits the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]; PRKCB protein inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [CYP1B1 protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene]] CTD PMID:10037446 NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
JBrowse link
G Prkce protein kinase C, epsilon decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRKCE mRNA CTD PMID:32553695 NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
JBrowse link
G Prkdc protein kinase, DNA-activated, catalytic subunit multiple interactions
decreases expression
increases expression
ISO 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [A gene mutant form results in decreased expression of PRKDC mRNA]
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PRKDC mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PRKDC protein
CTD PMID:25448685 NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
JBrowse link
G Prl prolactin increases metabolic processing
increases secretion
multiple interactions
EXP PRL protein results in increased metabolism of 9,10-Dimethyl-1,2-benzanthracene
9,10-Dimethyl-1,2-benzanthracene results in increased secretion of PRL protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Estradiol] results in increased secretion of PRL protein; [Estradiol co-treated with Progesterone co-treated with Hydrocortisone co-treated with PRL protein] affects the metabolism of 9,10-Dimethyl-1,2-benzanthracene
CTD PMID:3141044 PMID:8674863 NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
JBrowse link
G Procr protein C receptor increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PROCR mRNA CTD PMID:21527772 NCBI chr 3:144,254,596...144,258,863
Ensembl chr 3:144,254,380...144,258,903
JBrowse link
G Prr15 proline rich 15 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PRR15 mRNA CTD PMID:32553695 NCBI chr 4:83,432,002...83,435,582
Ensembl chr 4:83,431,758...83,437,436
JBrowse link
G Psat1 phosphoserine aminotransferase 1 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PSAT1 protein CTD PMID:38307155 NCBI chr 1:213,196,709...213,218,564
Ensembl chr 1:213,196,709...213,218,682
JBrowse link
G Psrc1 proline and serine rich coiled-coil 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PSRC1 mRNA CTD PMID:32553695 NCBI chr 2:196,022,361...196,026,874
Ensembl chr 2:196,022,361...196,026,874
JBrowse link
G Ptbp1 polypyrimidine tract binding protein 1 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTBP1 mRNA CTD PMID:12376462 NCBI chr 7:9,842,574...9,852,332
Ensembl chr 7:9,842,574...9,852,397
JBrowse link
G Ptger1 prostaglandin E receptor 1 multiple interactions
increases response to substance
ISO celecoxib inhibits the reaction [PTGER1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]; PTGS2 gene mutant form inhibits the reaction [PTGER1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene] CTD PMID:21739481 NCBI chr19:24,470,258...24,473,687
Ensembl chr19:24,467,532...24,473,559
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression
ISO
EXP
[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein; [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein; [9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PTGS2 mRNA; [epigallocatechin gallate co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA]; [Resveratrol co-treated with Glucaric Acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein; [theaflavin co-treated with Polylactic Acid-Polyglycolic Acid Copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA]; [Ursolic Acid co-treated with Glucaric Acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]; amarogentin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]; beta-elemene inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PTGS2 protein]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA]; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA]]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]]; dieckol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein]; Glucaric Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]]; Plant Extracts inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of PTGS2 protein]; PTGS2 gene mutant form inhibits the reaction [PTGER1 results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA]; Ursolic Acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mRNA]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PTGS2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA
[Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 protein; citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein]; Ghee inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 mRNA]; Resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTGS2 protein]
CTD PMID:12208745 PMID:16517061 PMID:16891317 PMID:20043298 PMID:21623034 More... NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
JBrowse link
G Ptms parathymosin affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of PTMS mRNA CTD PMID:21785161 NCBI chr 4:157,722,384...157,726,575
Ensembl chr 4:157,722,386...157,727,009
JBrowse link
G Ptn pleiotrophin decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PTN mRNA CTD PMID:32553695 NCBI chr 4:65,293,731...65,375,572
Ensembl chr 4:65,293,734...65,375,456
JBrowse link
G Ptp4a1 protein tyrosine phosphatase 4A1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PTP4A1 mRNA CTD PMID:32553695 NCBI chr 9:33,214,201...33,245,046
Ensembl chr 9:33,214,208...33,221,964
JBrowse link
G Ptpn13 protein tyrosine phosphatase, non-receptor type 13 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PTPN13 mRNA CTD PMID:32553695 NCBI chr14:6,108,202...6,282,619
Ensembl chr14:6,108,211...6,282,563
JBrowse link
G Ptpn22 protein tyrosine phosphatase, non-receptor type 22 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTPN22 mRNA CTD PMID:19480007 NCBI chr 2:191,366,761...191,414,782
Ensembl chr 2:191,366,808...191,414,779
JBrowse link
G Ptprcap protein tyrosine phosphatase, receptor type, C-associated protein increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of PTPRCAP mRNA CTD PMID:19480007 NCBI chr 1:201,449,133...201,451,293
Ensembl chr 1:201,449,113...201,451,288
JBrowse link
G Ptprg protein tyrosine phosphatase, receptor type, G decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PTPRG mRNA CTD PMID:32553695 NCBI chr15:12,871,706...13,552,186
Ensembl chr15:12,871,721...13,554,094
JBrowse link
G Ptprm protein tyrosine phosphatase, receptor type, M decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PTPRM mRNA CTD PMID:32553695 NCBI chr 9:106,639,573...107,343,698
Ensembl chr 9:106,639,573...107,343,698
JBrowse link
G Ptx3 pentraxin 3 increases expression
multiple interactions
ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PTX3 mRNA
[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of PTX3 mRNA
CTD PMID:32553695 NCBI chr 2:150,487,513...150,493,323
Ensembl chr 2:150,487,513...150,493,323
JBrowse link
G Rab12 RAB12, member RAS oncogene family affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of RAB12 mRNA CTD PMID:21785161 NCBI chr 9:106,480,301...106,506,895
Ensembl chr 9:106,480,301...106,506,910
JBrowse link
G Rabgap1l RAB GTPase activating protein 1-like decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of RABGAP1L mRNA CTD PMID:32553695 NCBI chr13:72,464,114...73,059,845
Ensembl chr13:72,468,110...73,059,984
JBrowse link
G Rad51 RAD51 recombinase increases expression
multiple interactions
EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 mRNA
A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 protein]; A gene mutant form inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 mRNA]
9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RAD51 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51 protein
CTD PMID:23969067 PMID:25448685 PMID:32553695 NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
JBrowse link
G Rad51ap1 RAD51 associated protein 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAD51AP1 protein CTD PMID:20025956 NCBI chr 4:159,759,454...159,772,473
Ensembl chr 4:159,759,459...159,772,524
JBrowse link
G Rad51b RAD51 paralog B decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of RAD51B mRNA CTD PMID:32553695 NCBI chr 6:98,096,525...98,640,988
Ensembl chr 6:98,098,868...98,640,979
JBrowse link
G Raf1 Raf-1 proto-oncogene, serine/threonine kinase multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RAF1 protein; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RAF1 protein] CTD PMID:22760862 NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
JBrowse link
G Rag1 recombination activating 1 multiple interactions ISO [CYP1B1 protein affects the susceptibility to 9,10-Dimethyl-1,2-benzanthracene] which affects the expression of RAG1 mRNA CTD PMID:27891153 NCBI chr 3:87,917,061...87,928,158
Ensembl chr 3:87,917,004...87,928,291
JBrowse link
G Ran RAN, member RAS oncogene family increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RAN mRNA CTD PMID:12376462 NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
JBrowse link
G Rarres2 retinoic acid receptor responder 2 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RARRES2 mRNA CTD PMID:19480007 NCBI chr 4:77,522,549...77,525,733
Ensembl chr 4:77,522,535...77,525,556
JBrowse link
G Rb1 RB transcriptional corepressor 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RB1 mRNA CTD PMID:32553695 NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
JBrowse link
G Rbp1 retinol binding protein 1 increases expression
increases expression
EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RBP1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RBP1 protein
DMBA increases expression of Rbp1 mRNA and protein in rat mammary gland
CTD
RGD
PMID:12376462 PMID:12376462 RGD:2292404 NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
JBrowse link
G Rbp4 retinol binding protein 4 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RBP4 protein CTD PMID:38307155 NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
JBrowse link
G Rel REL proto-oncogene, NF-kB subunit multiple interactions ISO 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[REL protein binds to NFKB1 protein] which binds to IL6 promoter]] CTD PMID:14678569 NCBI chr14:97,690,105...97,721,194
Ensembl chr14:97,695,161...97,720,892
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions
increases expression
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein binds to NFKB1 protein] which binds to IL6 promoter]]; [9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein; [Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RELA protein; Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein]]; Eugenol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of RELA protein]; NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of RELA protein]]
citronellol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA protein]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA mRNA]; tangeretin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA protein]
9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RELA protein
CTD PMID:14678569 PMID:20043298 PMID:24995432 PMID:31926054 PMID:37352108 NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
JBrowse link
G Rerg RAS-like, estrogen-regulated, growth-inhibitor decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RERG mRNA CTD PMID:19480007 NCBI chr 4:169,981,634...170,089,777
Ensembl chr 4:169,982,279...170,089,715
JBrowse link
G Rhoa ras homolog family member A decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RHOA protein CTD PMID:38307155 NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
JBrowse link
G Ripply3 ripply transcriptional repressor 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RIPPLY3 mRNA CTD PMID:21527772 NCBI chr11:33,648,471...33,656,587
Ensembl chr11:33,648,486...33,656,584
JBrowse link
G Rnd1 Rho family GTPase 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RND1 mRNA CTD PMID:32553695 NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
JBrowse link
G Rnf213 ring finger protein 213 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of RNF213 mRNA CTD PMID:32553695 NCBI chr10:104,656,329...104,755,669
Ensembl chr10:104,656,883...104,757,918
JBrowse link
G Rpl15 ribosomal protein L15 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RPL15 protein CTD PMID:38307155 NCBI chr15:7,503,883...7,507,166
Ensembl chr15:7,503,883...7,507,165
Ensembl chr12:7,503,883...7,507,165
JBrowse link
G Rpl6 ribosomal protein L6 increases expression EXP
ISO
9,10-Dimethyl-1,2-benzanthracene results in increased expression of RPL6 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of RPL6 protein
CTD PMID:12376462 PMID:38307155 NCBI chr12:35,347,493...35,352,011
Ensembl chr12:35,347,497...35,351,921
JBrowse link
G Rpl8 ribosomal protein L8 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RPL8 protein CTD PMID:38307155 NCBI chr 7:108,626,194...108,628,485
Ensembl chr 7:108,622,324...108,628,482
Ensembl chr 3:108,622,324...108,628,482
JBrowse link
G Rps6 ribosomal protein S6 decreases expression
increases expression
EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of RPS6 mRNA
9,10-Dimethyl-1,2-benzanthracene results in increased expression of RPS6 mRNA
CTD PMID:12097258 NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602
Ensembl chr 5:101,371,136...101,374,602
JBrowse link
G Rpsa ribosomal protein SA increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of RPSA protein CTD PMID:22248470 NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:119,851,225...119,855,247
JBrowse link
G Rrm2 ribonucleotide reductase regulatory subunit M2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RRM2 mRNA CTD PMID:32553695 NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773
JBrowse link
G Rrm2b ribonucleotide reductase regulatory TP53 inducible subunit M2B increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RRM2B mRNA CTD PMID:21704725 NCBI chr 7:69,077,024...69,108,742
Ensembl chr 7:69,078,291...69,108,633
JBrowse link
G S100a8 S100 calcium binding protein A8 affects expression
decreases expression
multiple interactions
ISO
EXP
9,10-Dimethyl-1,2-benzanthracene affects the expression of S100A8 mRNA
9,10-Dimethyl-1,2-benzanthracene results in decreased expression of S100A8 protein
[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of S100A8 protein
CTD PMID:21785161 PMID:22248470 PMID:38307155 NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
JBrowse link
G S100a9 S100 calcium binding protein A9 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of S100A9 protein CTD PMID:38307155 NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
JBrowse link
G S1pr1 sphingosine-1-phosphate receptor 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of S1PR1 mRNA CTD PMID:12376462 NCBI chr 2:206,309,715...206,314,070
Ensembl chr 2:203,621,587...203,629,681
JBrowse link
G Sac3d1 SAC3 domain containing 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SAC3D1 mRNA CTD PMID:32553695 NCBI chr 1:203,414,184...203,416,563
Ensembl chr 1:203,414,187...203,416,604
JBrowse link
G Sacs sacsin molecular chaperone increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SACS mRNA CTD PMID:32553695 NCBI chr15:35,285,783...35,370,335
Ensembl chr15:35,285,782...35,370,335
JBrowse link
G Scarb1 scavenger receptor class B, member 1 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SCARB1 mRNA CTD PMID:12376462 NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
JBrowse link
G Scd stearoyl-CoA desaturase increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SCD mRNA CTD PMID:12097258 PMID:12376462 NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
JBrowse link
G Scfd2 sec1 family domain containing 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SCFD2 mRNA CTD PMID:32553695 NCBI chr14:33,683,348...34,008,232
Ensembl chr14:33,683,273...34,008,213
JBrowse link
G Scmh1 Scm polycomb group protein homolog 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SCMH1 mRNA CTD PMID:32553695 NCBI chr 5:133,991,167...134,115,893
Ensembl chr 5:133,990,520...134,122,105
JBrowse link
G Sdc4 syndecan 4 affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of SDC4 mRNA CTD PMID:21785161 NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
JBrowse link
G Sdcbp syndecan binding protein affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of SDCBP mRNA CTD PMID:21785161 NCBI chr 5:19,473,499...19,517,188
Ensembl chr 5:19,489,961...19,527,572
JBrowse link
G Sec23a Sec23 homolog A, COPII coat complex component affects expression ISO 9,10-Dimethyl-1,2-benzanthracene affects the expression of SEC23A mRNA CTD PMID:21785161 NCBI chr 6:76,658,793...76,706,125
Ensembl chr 6:76,658,427...76,706,035
JBrowse link
G Selenop selenoprotein P decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SELENOP mRNA CTD PMID:12376462 NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
JBrowse link
G Sfn stratifin increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SFN mRNA CTD PMID:21527772 NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
JBrowse link
G Sfpq splicing factor proline and glutamine rich decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SFPQ protein CTD PMID:38307155 NCBI chr 5:139,338,034...139,353,476
Ensembl chr 5:139,338,075...139,353,472
JBrowse link
G Sfrp2 secreted frizzled-related protein 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SFRP2 mRNA CTD PMID:32553695 NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063
JBrowse link
G Slc12a2 solute carrier family 12 member 2 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SLC12A2 mRNA CTD PMID:12376462 NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440
JBrowse link
G Slc13a3 solute carrier family 13 member 3 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SLC13A3 mRNA CTD PMID:19480007 NCBI chr 3:154,141,878...154,204,604
Ensembl chr 3:154,141,872...154,204,606
JBrowse link
G Slc16a2 solute carrier family 16 member 2 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SLC16A2 mRNA CTD PMID:32553695 NCBI chr  X:68,725,365...68,848,572
Ensembl chr  X:68,723,261...68,848,771
JBrowse link
G Slc16a3 solute carrier family 16 member 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SLC16A3 mRNA CTD PMID:19480007 NCBI chr10:106,212,679...106,222,564
Ensembl chr10:106,212,778...106,222,562
JBrowse link
G Slc19a2 solute carrier family 19 member 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SLC19A2 mRNA CTD PMID:32553695 NCBI chr13:76,601,975...76,616,175
Ensembl chr13:76,601,900...76,616,172
JBrowse link
G Slc1a3 solute carrier family 1 member 3 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SLC1A3 mRNA CTD PMID:19480007 NCBI chr 2:57,755,495...57,830,605
Ensembl chr 2:57,755,497...57,830,605
JBrowse link
G Slc25a10 solute carrier family 25 member 10 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SLC25A10 mRNA CTD PMID:12376462 NCBI chr10:105,765,598...105,775,159
Ensembl chr10:105,765,372...105,773,556
JBrowse link
G Slc38a4 solute carrier family 38, member 4 decreases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of SLC38A4 mRNA CTD PMID:19480007 NCBI chr 7:128,142,866...128,203,000
Ensembl chr 7:128,144,807...128,202,995
JBrowse link
G Slc39a11 solute carrier family 39, member 11 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SLC39A11 mRNA CTD PMID:32553695 NCBI chr10:98,275,958...98,697,042
Ensembl chr10:98,275,960...98,611,295
JBrowse link
G Slc46a3 solute carrier family 46, member 3 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SLC46A3 mRNA CTD PMID:32553695 NCBI chr12:7,140,610...7,157,093
Ensembl chr12:7,140,668...7,157,092
JBrowse link
G Slc7a3 solute carrier family 7 member 3 increases expression EXP 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SLC7A3 mRNA CTD PMID:19480007 NCBI chr  X:66,210,071...66,216,482
Ensembl chr  X:66,210,081...66,215,708
JBrowse link
G Slit2 slit guidance ligand 2 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SLIT2 mRNA CTD PMID:32553695 NCBI chr14:62,616,337...62,955,934
Ensembl chr14:62,617,067...62,955,948
JBrowse link
G Slit3 slit guidance ligand 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SLIT3 mRNA CTD PMID:32553695 NCBI chr10:19,571,798...20,156,634
Ensembl chr10:19,571,684...20,156,634
JBrowse link
G Smyd3 SET and MYND domain containing 3 decreases expression ISO 9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of SMYD3 mRNA CTD PMID:32553695 NCBI chr13:90,709,263...91,266,209
Ensembl chr13:90,709,270...91,266,253
JBrowse link
G Snai1 snail family transcriptional repressor 1 increases expression ISO 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SNAI1 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of SNAI1 protein CTD PMID:29663660 NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
JBrowse link
G Snrnp70 small nuclear ribonucleoprotein U1 subunit 70 affects expression